JPH0219392A - Galactosaminooligosaccahride and production thereof - Google Patents
Galactosaminooligosaccahride and production thereofInfo
- Publication number
- JPH0219392A JPH0219392A JP16868188A JP16868188A JPH0219392A JP H0219392 A JPH0219392 A JP H0219392A JP 16868188 A JP16868188 A JP 16868188A JP 16868188 A JP16868188 A JP 16868188A JP H0219392 A JPH0219392 A JP H0219392A
- Authority
- JP
- Japan
- Prior art keywords
- polygalactosamine
- acid
- galactosamine
- culture
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000000126 substance Substances 0.000 claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 abstract description 36
- 102000004190 Enzymes Human genes 0.000 abstract description 36
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 241000589774 Pseudomonas sp. Species 0.000 abstract description 5
- 230000007062 hydrolysis Effects 0.000 abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 4
- 239000002246 antineoplastic agent Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 37
- 239000000243 solution Substances 0.000 description 31
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 30
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 30
- 235000002639 sodium chloride Nutrition 0.000 description 28
- 238000000862 absorption spectrum Methods 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 230000000694 effects Effects 0.000 description 23
- 239000002253 acid Substances 0.000 description 22
- 239000002609 medium Substances 0.000 description 22
- 229920001542 oligosaccharide Polymers 0.000 description 21
- 150000003839 salts Chemical class 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 150000002482 oligosaccharides Chemical class 0.000 description 18
- 239000002244 precipitate Substances 0.000 description 18
- 230000003287 optical effect Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 16
- 229910001868 water Inorganic materials 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 238000002844 melting Methods 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 230000001766 physiological effect Effects 0.000 description 11
- 238000000354 decomposition reaction Methods 0.000 description 10
- 238000000921 elemental analysis Methods 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 230000002776 aggregation Effects 0.000 description 8
- -1 hydrochloric acid Chemical class 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 229920005654 Sephadex Polymers 0.000 description 7
- 239000012507 Sephadex™ Substances 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- 229940041514 candida albicans extract Drugs 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 239000012138 yeast extract Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000593 degrading effect Effects 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 229920002101 Chitin Polymers 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000008351 acetate buffer Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 241001019529 Sarocladium bacillisporum Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003957 anion exchange resin Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000003311 flocculating effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 241001135516 Burkholderia gladioli Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- RJTZUHVCZIGJMB-UHFFFAOYSA-N hydron;1h-indole;chloride Chemical compound Cl.C1=CC=C2NC=CC2=C1 RJTZUHVCZIGJMB-UHFFFAOYSA-N 0.000 description 2
- 239000003317 industrial substance Substances 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000004317 sodium nitrate Substances 0.000 description 2
- 235000010344 sodium nitrate Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 150000004043 trisaccharides Chemical class 0.000 description 2
- 239000001052 yellow pigment Substances 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- PZUPAGRIHCRVKN-UHFFFAOYSA-N 5-[5-[3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]-5-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound OCC1OC(O)C(O)C(O)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(COC4C(C(O)C(O)CO4)O)O3)O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(COC2C(C(O)C(O)CO2)O)O1 PZUPAGRIHCRVKN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000818376 Homo sapiens Palmitoyltransferase ZDHHC17 Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- PWHVEHULNLETOV-UHFFFAOYSA-N Nic-1 Natural products C12OC2C2(O)CC=CC(=O)C2(C)C(CCC2=C3)C1C2=CC=C3C(C)C1OC(O)C2(C)OC2(C)C1 PWHVEHULNLETOV-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102100021061 Palmitoyltransferase ZDHHC17 Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 125000003550 alpha-D-galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000012225 czapek media Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FYKDNWHPKQOZOT-UHFFFAOYSA-M sodium;dihydrogen phosphate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].OP(O)([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FYKDNWHPKQOZOT-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000012134 supernatant fraction Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、アミノオリゴ糖、更に詳細には新規なガラク
トサミノオリゴ糖、及びその製造方法に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to amino-oligosaccharides, more particularly to novel galactosaminooligosaccharides, and methods for producing the same.
(従来の技術)
近年、微生物、植物あるいは動物の生産する多糖あるい
はそれらのオリゴ糖が種々の生理活性を有することが知
られるようになり、多糖又はそれらのオリゴ糖に関心が
高まっている。(Prior Art) In recent years, it has become known that polysaccharides or their oligosaccharides produced by microorganisms, plants, or animals have various physiological activities, and interest in polysaccharides and their oligosaccharides has increased.
そして例えばポリグルコサミン(キトサン)においても
、キチン、キトサン及びそのオリゴ糖が抗腫瘍活性とい
ったすぐれた生理活性を有することが発見されている。For example, in polyglucosamine (chitosan), it has been discovered that chitin, chitosan, and their oligosaccharides have excellent physiological activity such as antitumor activity.
また、ポリガラクトサミンも上記したポリグルコサミン
と類似の多糖類であることから、ポリガラクトサミンに
もすぐれた生理活性が期待され、ポリガラクトサミンに
対する関心が高まっている。Furthermore, since polygalactosamine is a polysaccharide similar to the above-mentioned polyglucosamine, polygalactosamine is expected to have excellent physiological activity, and interest in polygalactosamine is increasing.
(但し1式中nは0〜10を表わす)。(However, n in formula 1 represents 0 to 10).
しかしながら、ポリガラクトサミン(α−1,4−ガラ
クトサミノガラクタン)の内、微生物起源のものは非常
に少なく、例えば不完全菌由来のPF−101及びPF
−102が知られている程度であり (特公昭56−1
2639号、特開昭62−294093号)、本発明の
ような少糖類であるガラクトサミノオリゴ糖は従来全く
未知の化合物であって、新規である。However, there are very few polygalactosamines (α-1,4-galactosaminogalactan) derived from microorganisms, such as PF-101 and PF derived from B. deuteromycetes.
-102 is only known (Tokuko Sho 56-1
Galactosaminooligosaccharides, which are oligosaccharides such as those used in the present invention, are novel and completely unknown compounds.
(発明が解決しようとする問題点)
上記したPF−101、PF−102は、生理活性を有
するアミノ多糖類であるポリグルコサミンとは比較的類
縁の多糖であるにもかかわらず、強力な凝集活性以外に
は格別の生理活性が確認されていないのが技術の現状で
ある。(Problems to be Solved by the Invention) The above-mentioned PF-101 and PF-102 have strong aggregation activity despite being relatively related polysaccharides to polyglucosamine, which is an aminopolysaccharide with physiological activity. The current state of the technology is that no other particular physiological activity has been confirmed.
(問題点を解決するための手段)
本発明はこのような技術の現状に鑑みてなされたもので
あって、PF−101又はPF−102をベースとした
新規な生理活性物質を開発する目的でなされたものであ
る。(Means for Solving the Problems) The present invention was made in view of the current state of technology, and is aimed at developing a new physiologically active substance based on PF-101 or PF-102. It has been done.
そこで各方面から広く且つ深く検討した結果、これら多
糖類の分解生成物であるオリゴ糖に着目するに到った。As a result of extensive and deep research from various perspectives, we have focused on oligosaccharides, which are decomposition products of these polysaccharides.
そして分解方法1分離精製方法についても鋭意研究の結
果、各種のオリゴ糖をそれぞれ単離することに成功し、
且つそれらをそれぞれ同定してすべてが文献未載の新規
化合物であることを確認し、本発明を完成するに到った
ものである。As a result of intensive research on decomposition method 1 separation and purification method, we succeeded in isolating various oligosaccharides.
Moreover, by identifying each of them and confirming that all of them are new compounds that have not been described in literature, we have completed the present invention.
本発明に係るガラクトサミノオリゴ糖は、いずれも新規
物質であり、単独又は混合して抗腫瘍性等各種の有益な
生理活性が強く期待されるものである。The galactosaminooligosaccharides according to the present invention are all new substances, and are strongly expected to have various beneficial physiological activities such as antitumor properties, either alone or in combination.
本発明を実施するに際して、出発原料として、化学構造
が明確化され且つ微生物を起源とする大量生産安定供給
が確保されるという観点から、各種ポリガラクトサミン
の中から特に前記したPF−102に着目した。In carrying out the present invention, we focused on the above-mentioned PF-102 from various polygalactosamines as a starting material, from the viewpoint of having a clear chemical structure and ensuring a stable supply of mass production originating from microorganisms. .
PF−102は、D−ガラクトサミンが主にα−1,4
結合した分子量16万以上の塩基性多糖、α−1,4−
ポリガラクトサミンであって、次の式で示される天然多
糖類である:
このPF−102は、和歌両県の腐植層から分離した不
完全菌[1菌の培養液中に蓄積される凝集活性物質の1
つであって、培養液に塩類を添加して析出させた酸水溶
液溶解性の析出物を更に精製して得られたものであって
、次の理化学的性質を有するものである。In PF-102, D-galactosamine is mainly α-1,4
A basic polysaccharide with a molecular weight of 160,000 or more, α-1,4-
Polygalactosamine is a natural polysaccharide represented by the following formula. 1
It is obtained by further purifying a precipitate soluble in an acid aqueous solution precipitated by adding salts to a culture solution, and has the following physical and chemical properties.
(1)凝集活性;きわめて微量で懸濁微細物を凝集する
。(1) Agglomeration activity: Agglomerates suspended fine particles in extremely small amounts.
(2)凝集活性p)l範囲;pH2〜9で安定に凝集活
性を示す。(2) Aggregation activity p)l range: Stably exhibits aggregation activity at pH 2 to 9.
(3)凝集活性温度範囲;0−100℃で凝集活性が認
められる。(3) Temperature range for aggregation activity; aggregation activity is observed at 0-100°C.
(4)凝集活性イオン強度;炭酸およびFe2(SO4
)3により凝集活性が阻害されるがそれ以外の各種イオ
ン及びイオン強度によって凝集活性に影響はなく、Na
C1,K、SO4でIMまで全く影響を与えない。(4) Coagulation active ionic strength; carbonic acid and Fe2 (SO4
) 3 inhibits aggregation activity, but other ions and ionic strength have no effect on aggregation activity, and Na
C1, K, and SO4 have no effect on IM at all.
(5)元素分析;窒素8.64%、炭素42.80%、
水素6.87%
一般式:(Cj(□1NO4・スH20)ア(6)呈色
反応;ニンヒドリン反応 士キサントプロティン
反応
エーリッヒ反応
モリッシュ反応
フェノール硫酸法 士
レローゼンテスト
(7)電気泳動;密度勾配等重点電気泳動により単一物
質として確認され、等重点(pI)は8.5である。(5) Elemental analysis; nitrogen 8.64%, carbon 42.80%,
Hydrogen 6.87% General formula: (Cj (□1NO4・SuH20)a (6) Color reaction; Ninhydrin reaction; It was confirmed as a single substance by gradient isofocus electrophoresis, with an isofocus (pI) of 8.5.
(8)物質の色;淡黄色
(9)塩基性、酸性、中性の区別
0.5%w/vで水に懸濁した場合のPHは7.5(脱
イオン水のpH5,8)である。(8) Color of substance; light yellow (9) Distinction between basic, acidic, and neutral When suspended in water at 0.5% w/v, the pH is 7.5 (deionized water pH 5, 8) It is.
(10)溶剤に対する溶解性 ・熱水に難溶 ・冷水に難溶 ・希酸に易溶 ・希アルカリに難溶 ・アルコール類、アセトン、クロロホルム。(10) Solubility in solvents ・Poorly soluble in hot water ・Poorly soluble in cold water ・Easily soluble in dilute acids ・Poorly soluble in dilute alkali ・Alcohols, acetone, chloroform.
ベンゼン、n−ペンタンに不溶。Insoluble in benzene and n-pentane.
(11)平均分子量 16万以上
上記したPF−102の酸塩としては、燐酸塩、塩酸塩
、酢酸塩、乳酸塩、クエン酸塩などが例示される。(11) Average molecular weight: 160,000 or more Examples of the acid salt of PF-102 mentioned above include phosphate, hydrochloride, acetate, lactate, and citrate.
上記した凝集活性物質PF−102は、例えば本発明者
らが和歌山系の腐植層より分離した不完全菌1−1菌に
よって生産される。不完全菌[1菌はベニシロマイセス
属(Paecilo[1yces)に属すものと認めら
れ、ベニシロマイセス[1と命名され、該菌株は微工研
にFIERM P−3928(FERN BP−118
0)として寄託されている。The flocculating active substance PF-102 described above is produced, for example, by Deuteromycosis 1-1, which the present inventors isolated from a humus layer in the Wakayama region. Deuteromyces [1] was recognized as belonging to the genus Paecilo [1yces] and was named Benicillomyces [1.
0).
次にベニシロマイセスI −1(Paecilomyc
es r −1)の菌学的性質を示す。Next, Paecilomyces I-1 (Paecilomyces I-1)
es r -1).
[a]顕顕微上下の観察
本菌は分生胞子柄(conidiophore)を欠き
、分生胞子は栄養菌糸または栄養菌糸束から直接生えて
いる一本一本独立したフィアライド(phialide
)の先端に長い連鎖をなして派生している。フィアライ
ドは半透明で20〜45μの長さを持ち、基部はやや太
< (1,0〜1.5μ)先端はやや先細り(0,5〜
1.0μ)で、直線的あるいは先端部がやや湾曲したも
のもある。分生胞子は電子顕微鏡により葉巻タバコ型(
あるいは桿菌型)であり、そのサイズは4〜6X1.0
〜1.4μである。[a] Observation under and above the microscope This fungus lacks conidiophores, and conidia are individual phialides that grow directly from vegetative hyphae or vegetative hyphal bundles.
) is derived in a long chain at the tip. Phialide is translucent and has a length of 20 to 45μ, with a slightly thick base (1.0 to 1.5μ) and a slightly tapered tip (0.5 to 1.5μ).
1.0μ), and some have a straight or slightly curved tip. The conidia are cigar-shaped (
or rod type), and its size is 4 to 6 x 1.0
~1.4μ.
分生胞子は普通25〜35個の連鎖をなしているが、ま
れにはもつと長鎖のものもwt祭される。この分生胞子
の連鎖は非常にもろく、−寸したショックで簡単にくず
れる。Conidia usually form a chain of 25 to 35 conidia, but in rare cases, long-chain conidia are also observed. This chain of conidia is extremely fragile and can be easily broken by a severe shock.
〔b〕各培地における生育状態(25℃平面培養)(1
)ツアペック寒天培地
コロニーの生育は良く14日目上直径約45mmに達す
る。白色のビロード状から羊毛状の菌叢で、中央部に房
状に盛上りがあり、コロニー周辺は円形である。水滴・
シワ共になし。コロニー裏面は培養初期白色、培養後期
中央部が淡黄色を呈する。[b] Growth status in each medium (25°C flat culture) (1
) The colonies on Czapek agar medium grew well and reached a diameter of about 45 mm on the 14th day. The flora is white, velvety to woolly, with a tuft-like bulge in the center, and a circular area around the colony. Water drops/
No wrinkles. The underside of the colony is white in the early stage of culture, and the central part is pale yellow in the later stage of culture.
寒天への色素産生は認められない。No pigment production was observed on the agar.
(2)麦芽寒天培地
コロニーの生育は良く、14日目上直径約54+nm、
コロニー周辺は円形にならず梅林状を呈する。(2) Colonies on malt agar medium grew well, with a diameter of about 54+ nm on the 14th day.
The area around the colony is not circular but resembles a plum grove.
菌叢の中央部は白色だが、周辺部は淡黄色を呈する。菌
叢の厚さは中程度で、中央部はやや凹状である。水滴・
シワ共に認められず、コロニー裏面は全面淡黄色を呈す
。寒天培地に淡黄色色素の産生あり。The central part of the bacterial flora is white, but the peripheral part is pale yellow. The thickness of the flora is medium, and the central part is slightly concave. Water drops/
No wrinkles were observed, and the entire back surface of the colony was pale yellow. A pale yellow pigment was produced on the agar medium.
(3)ポテトデキストロース寒天培地
コロニーの生育は非常に良<14日目上直径約60av
+に達する。白色のビロード状乃至羊毛状の可成り厚い
菌叢を形成し、中央部はやや盛上り、皿中央部は淡い黄
色を呈するやや薄い菌叢、その周辺部は白色の比較的厚
い菌叢となる。表面にシワはないが数個のうすい褐色の
水滴が認められる。コロニー裏面に放射状の数本のシワ
があり、同心円状の黄色の濃淡が認められる。寒天への
淡黄色色素の拡散がある。(3) Potato dextrose agar medium colony growth is very good <about 60 av in diameter on day 14
Reach +. It forms a white, velvety to woolly, fairly thick bacterial flora, with a slightly swollen central area, a slightly pale yellow flora in the center of the plate, and a relatively thick white flora around it. . There are no wrinkles on the surface, but a few light brown water droplets can be seen. There are several radial wrinkles on the back of the colony, and concentric yellow shading can be observed. There is diffusion of pale yellow pigment into the agar.
(4) YpSs寒天培地(組成スターチ1.5%、イ
ーストエキス0.4%、 に、HPO40,1%、Mg
SO40,05%。(4) YpSs agar medium (composition: starch 1.5%, yeast extract 0.4%, HPO40.1%, Mg
SO40.05%.
寒天2%)
コロニーの生育は良好で14日目上直径約50mmに達
する。白色の全体にふっくらとした羊毛状の厚い菌叢で
ある。水滴・シワなし。コロニー裏面は特記すべき特徴
なし。色素産生なし。(Agar 2%) Colony growth was good and reached a diameter of about 50 mm on the 14th day. It is a fluffy, woolly, thick bacterial flora all over its white color. No water drops or wrinkles. The underside of the colony has no noteworthy features. No pigment production.
(5) MY2.寒天培地(組成グルコース20%、ポ
リペプトン0.5%、イーストエキス0.3%、モルト
エキス0.3%、寒天2%)
コロニーの生育はあまり良くなく14日目上直径約30
+IImである。気菌糸はあまりたたず細かいシワが多
く、周辺部、は淡黄色、中央部は淡褐色を呈する。コロ
ニーの裏面は淡黄色で、細かいシワがある0色素産生な
し。(5) MY2. Agar medium (composition: glucose 20%, polypeptone 0.5%, yeast extract 0.3%, malt extract 0.3%, agar 2%) Colony growth was not very good, with a diameter of about 30 mm on the 14th day.
+IIm. Aerial mycelium does not form much and there are many fine wrinkles, and the peripheral part is pale yellow and the central part is pale brown. The underside of the colony is pale yellow with fine wrinkles and no pigment production.
以上の形態的特徴及び培養上の性質から本菌はモノフィ
アライド(monophialide)の不完全菌と考
えられオニオンとパロン共著のmonophialid
icspecies of Paecilomyces
(Agnes、 H,S、 0nionsand G、
L、 Barron; 1967、Mycologi
cal papersNo、107、Co@monすa
alth Mycological In5titut
e。Based on the above morphological characteristics and culture properties, this bacterium is considered to be a monophialide deficient bacterium.
icspecies of Paecilomyces
(Agnes, H, S, 0nionsand G,
L, Barron; 1967, Mycology
cal papers No. 107, Co@monsa
alth Mycological In5titut
e.
Key、 England)に記載されているペエシロ
マイセスバシリスポラス(Paecilomyces
bacillisporus)の特徴に類似している点
が多い。Paecilomyces bacillisporus, described in Key, England).
bacillisporus).
即ち不完全菌の分類1最も重要な特徴とされる分生胞子
の形態はP、 bacillisporusの分生胞子
の形態に極めて似ており、マイアライドの形態なども良
く似ている。しかし、一方各種の培地での培養上の特徴
については多少の差違が認められ、上記文献の記載のP
、 bacillisporusは生育速度が本菌に比
較して遅く、菌糸は初期白色、培養後期に桃色がかる(
pinkish)と記述されているが、本菌では初期白
色、培地によっては後期淡黄色を呈する点で異なる。し
かし前述文献にも
P、 bacillisporusの菌株には培養上の
特徴や分生胞子の大きさにおいて変動がある。(Str
ains ofP、 bacillisporus s
how variation in cultural
characteristics and in 5p
are 5ize)と記述されていることを考慮すると
、本菌はPaecilomycesbacillisp
orusかその類縁菌と考えられるが決定的根拠がない
のでベニシロマイセスI−1とした。That is, the morphology of the conidia, which is considered the most important characteristic of Classification 1 of Deuteromycota, is extremely similar to that of P. bacillisporus, and the morphology of the myalides is also very similar. However, on the other hand, there are some differences in culture characteristics in various media, and P
The growth rate of Bacillisporus is slower than that of this fungus, and the hyphae are white in the early stage and pinkish in the late stage of culture (
This bacterium differs in that it is initially white and depending on the culture medium, it becomes pale yellow in its later stages. However, even in the above-mentioned literature, P. bacillisporus strains vary in culture characteristics and conidial size. (Str
ains of P, bacillisporus s
how variation in cultural
Characteristics and in 5p
5ize), this bacterium is Paecilomyces bacillisp.
It is thought to be Benicillomyces orus or a related bacterium, but since there is no conclusive evidence, it was designated as Benicillomyces I-1.
不完全菌の分類上の指標としてはあまり重要視されない
性質であるが1次に本閑の生理学的性質について示す。Although this property is not considered very important as an indicator for the classification of Deuteromycota, the physiological properties of Honkan will be shown below.
〔C〕生理的性質
(1)炭素源の利用性
ツアペック培地を基本培地としてその蔗糖の代りに各種
の炭素源を加えて、生育度をみた結果、可溶性澱粉、グ
リコーゲン、トレハロース、ラフィノース、セロビオー
ス、マルトース、蔗糖、グルコース、フラクトース、ガ
ラクトース、マンノース、イノシトール、ソルビトール
、グリセリンを非常に良く利用する。[C] Physiological properties (1) Availability of carbon sources Using Czapek's medium as a basic medium, various carbon sources were added in place of sucrose, and the growth was observed. As a result, soluble starch, glycogen, trehalose, raffinose, cellobiose, It makes great use of maltose, sucrose, glucose, fructose, galactose, mannose, inositol, sorbitol, and glycerin.
次にイヌリン、ラクトース、アラビノース、リボース、
マニトール、乳酸、コハク酸は可成り良く利用出来た。Next, inulin, lactose, arabinose, ribose,
Mannitol, lactic acid, and succinic acid could be used fairly well.
キシロース、ラムノース、クエン酸の利用性は低く、酒
石酸、シュウ酸は全く利用出来ない。The availability of xylose, rhamnose, and citric acid is low, and the availability of tartaric acid and oxalic acid is completely unavailable.
(2)窒素源の利用性
ツアペック培地を基本培地としてその窒素源を色々変え
て生育度をみた結果、アンモニア態、アミノ態、硝酸態
のいずれの窒素をも良く利用出来る。(2) Utilization of nitrogen source As a result of using Czapek's medium as a basic medium and changing the nitrogen source to see the growth rate, it was found that any of the ammonia, amino, and nitrate forms of nitrogen can be utilized well.
(3)生育温度
最適生育温度は23〜25℃であり、30’Cでは生育
がみられるが、35℃では生育出来ない。(3) Growth temperature The optimal growth temperature is 23 to 25°C, and growth is observed at 30'C, but not at 35°C.
(4)生育PH
G、Ye培地(組成グルコース2%、酵母エキス0.2
%)でPH2〜10の範囲で生育をみたところ、いずれ
のpHでも良く生育した。(4) Growth PH G, Ye medium (composition glucose 2%, yeast extract 0.2
When the growth was observed in the pH range of 2 to 10 (%), it grew well at any pH.
ペーシロマイセスI−1は通常の糸状菌の液体培養方法
で培養することができる。Paecilomyces I-1 can be cultured by a conventional liquid culture method for filamentous fungi.
ペーシロマイセスI−1の胞子または菌糸を液体培地に
接種し、好気的に培養する。炭素源としてはブドウ糖、
麦芽糖、蔗糖、R粉、廃糖蜜等を使用することが出来る
が好ましくはブドウ糖を用いるのが良い、窒素源として
は硫酸アンモニウム、硝酸ソーダなどの無機窒素、ペプ
トン、酵母エキスなどの有機窒素が使用出来る。Spores or hyphae of Paecilomyces I-1 are inoculated into a liquid medium and cultured aerobically. Glucose as a carbon source,
Maltose, sucrose, R powder, blackstrap molasses, etc. can be used, but it is preferable to use glucose. As a nitrogen source, inorganic nitrogen such as ammonium sulfate and sodium nitrate, and organic nitrogen such as peptone and yeast extract can be used. .
培養温度は本凝集活性物質生産菌が凝集活性物質を生産
する範囲内で適宜変更し得るが通常は20〜25℃で培
養することが好ましい。培養時間は培養条件によって異
なるが、通常4〜5日程度であり、凝集活性物質が最高
に達する時間を見積って適当な時間に終了すればよい。Although the culture temperature can be changed as appropriate within the range in which the flocculating active substance-producing bacteria produce the flocculating active substance, it is usually preferable to culture at 20 to 25°C. The culture time varies depending on the culture conditions, but is usually about 4 to 5 days, and the culture may be terminated at an appropriate time by estimating the time when the agglutinating active substance reaches its maximum.
本発明においては、培養濾液または濾液濃縮液に各種塩
を添加し、沈澱が生じない場合は必要によってはアルカ
リを添加してpHを7〜9として、析出させ、析出物を
分離し、水洗し、これを希酸水溶液に溶解し、再び塩を
添加するか、アルカリ等の添加によってPHを7〜9と
して、析出させて、高度に精製されたPF−102を得
ることができる。In the present invention, various salts are added to the culture filtrate or filtrate concentrate, and if precipitation does not occur, an alkali is added as necessary to adjust the pH to 7 to 9 to cause precipitation, and the precipitate is separated and washed with water. Highly purified PF-102 can be obtained by dissolving this in a dilute acid aqueous solution, adding a salt again, or adjusting the pH to 7 to 9 by adding an alkali or the like, and precipitating it.
PF−102の含有液に添加される塩としては、次の例
示の塩を含めて塩の1又は2以上である。The salt added to the solution containing PF-102 is one or more salts including the following exemplified salts.
即ち、塩化カリ、塩化ナトリウム、塩化カルシウム、塩
化アンモニアなどの塩酸塩、硝酸カリ、硝酸ナトリウム
などの硝酸塩、酢酸ソーダなどの酢酸塩、硫酸2カリ、
硫安、硫酸カルシウム、硫酸銅などの硫酸塩、リン酸2
カリ、リン酸1カリ、リン酸2ソーダ、リン酸1ソーダ
などのリン酸塩などが例示される。Namely, hydrochlorides such as potassium chloride, sodium chloride, calcium chloride, and ammonia chloride, nitrates such as potassium nitrate and sodium nitrate, acetates such as sodium acetate, dipotassium sulfate,
Sulfates such as ammonium sulfate, calcium sulfate, copper sulfate, phosphoric acid 2
Examples include phosphates such as potash, monopotassium phosphate, disodium phosphate, and monosodium phosphate.
添加する塩は溶解した状態であれば、どれでもよいが、
好ましいのはPF−102含有液に対し0.5〜50%
、より好ましくは2〜40%程度である。Any salt can be added as long as it is dissolved, but
The preferred amount is 0.5 to 50% based on the PF-102 containing liquid.
, more preferably about 2 to 40%.
添加する塩の種類によってはpl+が7以上になるので
、この場合はpHの調整を行なうことなく、PF−10
2が析出するので、析出物を分離すればよし1a
塩を添加しても析出を生じない場合はカセイソーダ等の
アルカリを用いて、pHを7〜9、好ましくは等電点で
ある8、5附近にpH調整を行えばよい。Depending on the type of salt added, pl+ may be 7 or more, so in this case, PF-10 can be obtained without adjusting the pH.
2 precipitates, so it is enough to separate the precipitate 1a If no precipitation occurs even after adding salt, use an alkali such as caustic soda to adjust the pH to 7 to 9, preferably 8 to 5, which is the isoelectric point. The pH may be adjusted nearby.
PF−102含有液に塩の添加と場合によってp117
〜9の調整を行えば、夾雑物の妨害によって容易に析出
しなかったPF−102が析出を起し、夾雑物とは分離
して析出する。この析出物は遠心分離又は濾布による濾
過によって分離できる。Addition of salt to PF-102-containing solution and optionally p117
By performing the adjustment in steps 9 to 9, PF-102, which did not easily precipitate due to the interference of impurities, will start to precipitate, and will be separated from the impurities and precipitated. This precipitate can be separated by centrifugation or filtration with a filter cloth.
培養液をPH8,5の等電点処理をしてもPF−102
の析出は全く起らなかったことからみれば、塩の添加だ
けでPF−102の析出が完全に起るということはきわ
めて意外なことである。Even if the culture solution is subjected to isoelectric point treatment at pH 8.5, PF-102 remains
Considering that no precipitation of PF-102 occurred at all, it is extremely surprising that the addition of salt alone causes complete precipitation of PF-102.
分離した析出物は多量の塩を含んでいるので、これを水
や溶媒で洗滌して脱塩し、酸に溶解する。Since the separated precipitate contains a large amount of salt, it is washed with water or a solvent to desalt it, and then dissolved in acid.
酸としては酢酸などの有機塩、塩酸などの無機酸などい
ずれの酸でもよく、また、濃度としては0.01〜3モ
ル程度のものがよい。The acid may be any acid such as an organic salt such as acetic acid or an inorganic acid such as hydrochloric acid, and the concentration is preferably about 0.01 to 3 mol.
析出物を酸に溶解した後は、2117〜9の等電点附近
の処理のみで容易に析出するようになっているので、カ
セイソーダ等のアルカリを添加し、pH7〜9、好まし
くはpH8,5とpH調整し、析出物を得る。After dissolving the precipitate in acid, the precipitate is easily precipitated by only treatment near the isoelectric point of 2117-9, so add an alkali such as caustic soda and adjust the pH to 7-9, preferably pH 8.5. and adjust the pH to obtain a precipitate.
更に、精製するためには、この析出物を水等で洗滌し、
再び酸に溶解し、pH7〜9のpH調整を行い、析出物
を得ることができる。Furthermore, in order to purify this precipitate, wash it with water etc.
A precipitate can be obtained by dissolving in acid again and adjusting the pH to 7 to 9.
この精製処理は何度でも行なうことができ、精製が完了
した時点で、析出物はほぼ純粋となり、前記した化学構
造を有するα−1,4−ガラクトサミノガラクタンであ
るPF−102が得られるのである。This purification process can be repeated any number of times, and when the purification is completed, the precipitate becomes almost pure and PF-102, an α-1,4-galactosaminogalactan having the chemical structure described above, is obtained. It is.
このようにして得たポリガラクトサミン(PF−102
)を酸やアルカリ又は酵素で加水分解した後、単離精製
すれば目的とするガラクトサミノオリゴ糖を単品である
いは数種類を混合物として得ることができる。Polygalactosamine (PF-102) thus obtained
) can be hydrolyzed with acid, alkali or enzyme, and then isolated and purified to obtain the target galactosaminooligosaccharides singly or as a mixture of several types.
例えば酸加水分解の場合は、塩酸等常用される酸液を用
いて、通常、加温しながら酸加水分解を行うのである。For example, in the case of acid hydrolysis, a commonly used acid solution such as hydrochloric acid is used, and acid hydrolysis is usually performed while heating.
しかる後に、減圧濃縮したり、または、濾液を活性炭で
脱色した後アニオン交換樹脂で処理したりして、塩酸を
除去する。このようにして得たガラクトサミノオリゴ糖
混液をクロマ1−グラフィー等分離精製処理に付して、
各フラクションを回収し、各ガラクトサミノオリゴ糖を
それぞれ単離すればよい。Thereafter, hydrochloric acid is removed by concentration under reduced pressure, or by decolorizing the filtrate with activated carbon and treating it with an anion exchange resin. The thus obtained galactosaminooligosaccharide mixture is subjected to separation and purification treatment such as chroma 1-graphy,
Each fraction may be collected and each galactosaminooligosaccharide may be isolated.
このように、ポリガラクトサミンを酸又はアルカリによ
って加水分解することによりオリゴ糖を得ることができ
るのであるが、オリゴマー、特に重合度の高いものの収
率が比較的低い0例えば塩酸によってポリガラクトサミ
ンを加水分解する時、ランダムな分解の結果、得られる
オリゴ糖の量はモノ−ガラクトサミン、ジ−ガラクトサ
ミン、トリーガラクトサミン、テトラ−ガラクトサミン
、ペンタ−ガラクトサミンの順であり、重合度が大きい
程その収量は低下するということになる。As described above, oligosaccharides can be obtained by hydrolyzing polygalactosamine with acid or alkali, but the yield of oligomers, especially those with a high degree of polymerization, is relatively low. As a result of random decomposition, the amount of oligosaccharides obtained is in the order of mono-galactosamine, di-galactosamine, tri-galactosamine, tetra-galactosamine, and penta-galactosamine, and the higher the degree of polymerization, the lower the yield. It turns out.
そこで、ポリガラクトサミンを分解して、重合度が比較
的大きな種々の重合度のオリゴ糖を得るには、上記のよ
うに化学的方法によったのでは収率等の面から限界があ
るとの観点に達し、検討の結果、生物学的方法に着目す
るに到った。つまり、ポリガラクトサミンを分解して重
合度の異なる各種オリゴ糖を高収率で生産することので
きるポリガラクトサミン分解酵素の必要性がクローズア
ップされてきたのである。Therefore, in order to obtain oligosaccharides with relatively large degrees of polymerization by decomposing polygalactosamine, the chemical method described above has a limit in terms of yield. After reaching a point of view and considering it, we decided to focus on biological methods. In other words, the need for polygalactosamine-degrading enzymes that can degrade polygalactosamine and produce various oligosaccharides with different degrees of polymerization at high yields has been highlighted.
そこで本発明者らは、広範な微生物についてはポリガラ
クトサミン分解菌を検索した結果、シュードモナス属に
属する細菌が、新規なポリガラクトサミン分解酵素を生
産することを見出し、この酵素を利用することにより新
規なオリゴ糖を各種得ることに成功したものである。As a result of searching for polygalactosamine-degrading bacteria among a wide range of microorganisms, the present inventors discovered that bacteria belonging to the genus Pseudomonas produce a novel polygalactosamine-degrading enzyme. We succeeded in obtaining various oligosaccharides.
この新規なポリガラクトサミン分解酵素の理化学的性質
は次のとおりである:
(1)作用および基質特異性
ポリガラクトサミン(α−1,4ガラクトサミノガラク
タン)に作用してオリゴガラクトサミンを生成する。The physicochemical properties of this novel polygalactosamine-degrading enzyme are as follows: (1) Action and substrate specificity It acts on polygalactosamine (α-1,4 galactosaminogalactan) to produce oligogalactosamine.
その他の多糖類、例えばポリヘキソース、キチン、澱粉
(α−1,4グルカン)、グリコーゲン(α−1,4グ
ルカン)、プルラン(α−1,4グルカン)、デキスト
ラン(α−1,6グルカン)、ラミナラン(β〜1.3
グルカン)、カルボキシルセルロース(β−1,4−グ
ルカン)、キトサン(β−1,4−ゲルコサミノグルカ
ン)、エチレングリコールキチン(β−1,4N−アセ
チルゲルコサミノグルカン)、
Pssudomonas solanacearumの
N−アセチルガラクトサミノガラクタン(β−1,3N
−アセチルガラクトサミノガラクタン)(Y、 Aki
yama、、at、 al、、Agric。Other polysaccharides such as polyhexose, chitin, starch (α-1,4 glucan), glycogen (α-1,4 glucan), pullulan (α-1,4 glucan), dextran (α-1,6 glucan) , laminaran (β~1.3
glucan), carboxylcellulose (β-1,4-glucan), chitosan (β-1,4-gelcosaminoglucan), ethylene glycol chitin (β-1,4N-acetylgelcosaminoglucan), N of Pssudomonas solanacearum -Acetylgalactosaminogalactan (β-1,3N
-acetylgalactosaminogalactan) (Y, Aki
yama,, at, al,, Agric.
Biol、 Ches、、50(3)747.1986
)などには全く作用しない。Biol, Ches., 50(3)747.1986
) etc. have no effect at all.
(2)至適pH及び安定pH範囲
クエン酸リン酸ナトリウム緩衝液を用いた場合、至適p
Hは4.5〜7.0であり、安定範囲はpHは4.5〜
8.0である。(2) Optimal pH and stable pH range When using sodium citrate phosphate buffer, the optimal pH
H is 4.5 to 7.0, and the stable range is pH 4.5 to 7.0.
It is 8.0.
(3)酵素活性の測定法
酵素活性は基質にPaecilomyees I −1
菌の生産するPF−11又はPF−102(その主構成
糖はα−1,4ガラクトサミノガラクタン)を用いた、
この0.5%10.1モル酢酸緩衝液pH6,0溶液0
、5m12に酵素溶液0 、5m12を加え、37℃
、10分間反応させ、生じる還元力をSomogyi−
Nelson法で測定した。なお酵素単位は1分間当り
に1μモルのガラクトサミンに相当する還元力を増加さ
せる活性を1単位とした。(3) Enzyme activity measurement method Enzyme activity was measured using Paecilomyees I-1 as a substrate.
Using PF-11 or PF-102 (the main constituent sugar is α-1,4 galactosaminogalactan) produced by the fungus,
This 0.5% 10.1M acetate buffer pH 6,0 solution 0
, add 0.5 m12 of enzyme solution to 5 m12, and heat at 37°C.
, react for 10 minutes, and reduce the resulting reducing power with Somogyi-
Measured by Nelson method. Note that one unit of the enzyme was defined as an activity that increases the reducing power equivalent to 1 μmol of galactosamine per minute.
(4)作用適温及び温度安定性の範囲
20〜70℃の範囲で測定した結果、この酵素の至適温
度は55℃であり、それ以上で急激に低下する。(4) Range of suitable temperature and temperature stability for action As a result of measurements in the range of 20 to 70°C, the optimum temperature for this enzyme is 55°C, and the temperature decreases rapidly above this temperature.
つぎに温度安定性についてみた。pHl1i、0の条件
で各温度で0〜80分間保った時の残存活性をみたとこ
ろ、50℃、1時間で70%の活性が残存している。Next, we looked at temperature stability. When the residual activity was observed when kept at each temperature for 0 to 80 minutes under the condition of pHl1i, 0, 70% of the activity remained after 1 hour at 50°C.
(5)金属イオン等の影響
各種金属イオン及び阻害剤1 mM (PCMBのみ0
.1mM)を含む溶液中に37℃、1時間放置後、残存
酵素活性を測定し、相対値で示した。(表−1)表−1
,金属等の影響
阻害物 残存活性(%) 阻害物 残存活性(%
)無添加 100
KCI 96 NaClCaC
1,98LiCl
BaCl299 MnCl2CoCl288
NiC1゜CdCl298 5n
C12
FeC1,5FeC1゜
ZnC1,92HgC12
Pb(C1l、C00)295 N)14C
1(NH4)−SO4,100CuS04tris l
) 97 SDS 2)NBS 3
) 88 EDTA 4)阿IA
5) 100 PCMB 6)1)
トリス(ヒドロキシル)アミノメタン2)ドデシル硫酸
ナトリウム
3) N−ブロモコハク酸イミド
4)エチレンジアミン四酢酸二ナトリウム5)モノヨー
ド酢醸
6)パラオキシ安息香酸第二水銀
以上の結果から、このポリガラクトサミン分解酵素はス
ズ、鉄、銅、無機水銀及びSO8により阻害される。(5) Effects of metal ions, etc. Various metal ions and inhibitors 1 mM (PCMB only 0
.. After standing in a solution containing 1mM) at 37°C for 1 hour, the residual enzyme activity was measured and expressed as a relative value. (Table-1) Table-1
, metals, etc. Inhibitor Residual activity (%) Inhibitor Residual activity (%
) Additive-free 100 KCI 96 NaClCaC
1,98LiCl BaCl299 MnCl2CoCl288
NiC1゜CdCl298 5n
C12 FeC1,5FeC1゜ZnC1,92HgC12 Pb(C1l, C00)295 N)14C
1(NH4)-SO4,100CuS04tris l
) 97 SDS 2) NBS 3
) 88 EDTA 4) AIA
5) 100 PCMB 6)1)
Tris(hydroxyl)aminomethane 2) Sodium dodecyl sulfate 3) N-bromosuccinimide 4) Disodium ethylenediaminetetraacetate 5) Monoiodo vinegar 6) Mercuric paraoxybenzoate Based on the above results, this polygalactosamine degrading enzyme is , iron, copper, inorganic mercury and SO8.
(6)酵素の精製法 本酵素の単離、精製は常法に従って行うことができる。(6) Enzyme purification method Isolation and purification of this enzyme can be performed according to conventional methods.
例えば、エタノールによる沈殿物をセファデックスG−
50カラムクロマトグラフイー、側−セファデックスC
−25カラムクロマトグラフイーフエニル−セファロー
ス4Bカラムクロマトグラフイーなどの精製手段又はこ
れらの組合せにより精製される。For example, precipitate with ethanol and Sephadex G-
50 column chromatography, side-Sephadex C
-25 column chromatography, phenyl-Sepharose 4B column chromatography, or a combination thereof.
(7)分子量
本酵素の分子量はポリアクリルアミドゲルスラブ電気泳
動法により測定すると、31,000と計算される。(7) Molecular Weight The molecular weight of this enzyme is calculated to be 31,000 when measured by polyacrylamide gel slab electrophoresis.
(8)ポリアクリルアミドゲル電気泳動精製酵素を常法
に従って、7.5%のポリアクリルアミドゲル(pH8
,6)電気泳動にかけたところ、単一のバンドが認めら
れた。(8) Polyacrylamide gel electrophoresis The purified enzyme was purified using a 7.5% polyacrylamide gel (pH 8) according to a conventional method.
, 6) When subjected to electrophoresis, a single band was observed.
(9)等重点
常法によりシュークロース密度勾配の等電点電気泳動を
行った。その結果、この酵素の等重点はρI=6.7で
ある。(9) Isoelectric focusing of sucrose density gradient was performed using the conventional isofocus method. As a result, the isopoint of this enzyme is ρI=6.7.
本酵素は、その作用及び基質特異性において従来全く知
られていない新規酵素である。This enzyme is a novel enzyme whose action and substrate specificity are completely unknown.
上記したポリガラクトサミン分解酵素は5例えばシュー
ドモナスsp H881によって生産される。The polygalactosamine-degrading enzyme mentioned above is produced by, for example, Pseudomonas sp H881.
シュードモナスsp t1881は本発明者らが土壌中
より分離した菌株であり、その菌学的性質は下記のとう
りである。Pseudomonas sp t1881 is a strain that the present inventors isolated from soil, and its mycological properties are as follows.
(a)形態
顕微鏡的′11察(肉汁寒天培地30℃、16時間培養
)(1)細胞の大きさ:0.3〜0.6X1.O〜2.
0ミクロンの桿菌
(2)細胞の多形性:認められない
(3)運動性:極鞭毛を有し、運動性有り(4)胞子の
有無:形成せず
(5)ダラム染色性:陰性
(6)抗酸性:陰性
(b)各種培地における生育状態
(1)肉汁寒天平板培養:30℃、24時間でうす黄茶
色のコロニー、表面円滑で光沢を有し半ないし不透明で
ある。色素の生成はない。(a) Morphological microscopic observation (cultured on broth agar medium at 30°C for 16 hours) (1) Cell size: 0.3-0.6X1. O~2.
0 micron bacilli (2) Cell pleomorphism: Not observed (3) Motility: Possesses polar flagella and is motile (4) Presence or absence of spores: Not formed (5) Durham staining: Negative ( 6) Acid-fastness: Negative (b) Growth status in various media (1) Broth agar plate culture: Colonies are light yellow-brown in color when grown at 30°C for 24 hours, with a smooth, glossy surface and semi- to opaque. There is no pigment formation.
(2)肉汁寒天斜面培養:よく生育する。(2) Broth agar slant culture: Grows well.
(3)肉汁液体培養:培養液表面に厚膜状に生育、液内
には中程度に生育6
(4)肉汁ゼラチン穿刺培養二表面に生育し、層状に液
化する。(3) Meat juice liquid culture: Grows in a thick film on the surface of the culture solution, moderate growth in the liquid 6 (4) Meat juice gelatin puncture culture Grows on the surface and liquefies in layers.
(5)リドマスミルク:アルカリ性、完全に液化する。(5) Lidomus milk: alkaline, completely liquefied.
(c)生理的性質
(1)硝酸塩の還元:陰性
(2)脱窒反応:陰性
(3) MRテスト:陽性
(4) VPテスト:陰性
(5)インドールの生成:陰性
(6)硫化水素の生成:陰性
(7)澱粉の加水分解:陰性
(8)クエン酸の利用:コーザー、クリステンセンの両
培地で利用する。(c) Physiological properties (1) Nitrate reduction: Negative (2) Denitrification reaction: Negative (3) MR test: Positive (4) VP test: Negative (5) Indole production: Negative (6) Hydrogen sulfide Production: Negative (7) Starch hydrolysis: Negative (8) Use of citric acid: Used in both Koser and Christensen's media.
(9)無機窒素の利用:硝酸塩、アンモニアとも利用す
る。(9) Use of inorganic nitrogen: Nitrate and ammonia are also used.
(10)色素の生成: KingA i陰性、King
B ;弱い青蛍光の色素を生成、F agar +、弱
い青蛍光の色素を生成、P agar ;陰性
(11)ウレアーゼ:陽性
(12)オキシダーゼ:陽性
(13)カタラーゼ:陽性
(14)生育の範囲:生育Pl+5〜9、至適温度30
〜40℃
(15)酸素に対する態度:好気性
(16) O−Fナス1−:酸化
(17)カゼインの分解:陽性
(18) DNAの分解:陽性
(19)耐塩性:2%食塩;陽性、5%食塩;陰性(2
0)糖類から酸及びガスの生成
酸の生成 ガスの生成
(1) L−アラビノース +
(2)D−キシロース +
(3)D−グルコース +
(4)D−マンノース +
(5)D−フラクトース
(6)D−ガラク1−−ス +
(7)マルトース
(8)シュークロース +
(9)ラクトース
(10)トレハロース +
(+1) D−ソルビトール
(12) D−マンニトール
(13)イノシトール
(14)グリセリン
(15)デンプン
(d)その他の性質
(1)窒素源欠乏培地で菌体内にポリ−β−ハイドロキ
シブチル酸エステル(PH8)を蓄積する。(10) Pigment production: KingA i negative, King
B: produces a weak blue fluorescent dye, Fagar +, produces a weak blue fluorescent dye, Pagar: negative (11) urease: positive (12) oxidase: positive (13) catalase: positive (14) Growth range : Growth Pl+5-9, optimum temperature 30
~40℃ (15) Attitude towards oxygen: Aerobic (16) O-F Eggplant 1-: Oxidation (17) Casein degradation: Positive (18) DNA degradation: Positive (19) Salt tolerance: 2% salt; Positive , 5% salt; negative (2
0) Generation of acid and gas from sugars Generation of acid Generation of gas (1) L-arabinose + (2) D-xylose + (3) D-glucose + (4) D-mannose + (5) D-fructose ( 6) D-galactose + (7) maltose (8) sucrose + (9) lactose (10) trehalose + (+1) D-sorbitol (12) D-mannitol (13) inositol (14) glycerin ( 15) Starch (d) Other properties (1) Accumulates poly-β-hydroxybutyric acid ester (PH8) in bacterial cells in a nitrogen source-deficient medium.
(2)アルギニン、ベタインを唯一の炭素源として生育
し、アルギニンデヒドロラーゼ活性を持たない。(2) It grows using arginine and betaine as the sole carbon source and does not have arginine dehydrolase activity.
(3)脂肪酸(ツイーン80.60.20)を分解する
。(3) Decompose fatty acids (Tween 80.60.20).
(4) 40℃で生育する。4℃では生育不能。(4) Grows at 40℃. Unable to grow at 4°C.
上述の新規なポリガラクトサミン分解酵素生産能を有す
る本菌の分類学的性質を、「バージエズ・マニュアル・
オブ・デターミイテイブ・バクテリオロジー」第8版(
1974年)及び「バージエズ・マニュアル・オブ・シ
ステマテイツク・バクテリオロジー」第1巻(1984
年)の分類と対比すると、本菌はグロスファクターを要
求せず、PH8を蓄積し、アルギニン、ベタインを唯一
の炭素源として生育し、アルギニン・デヒドロラーゼ陰
性、脱窒反応陰性、40°Cで生育可能からセクション
2(あるいはItNAグループ2)のP、 cepac
ia、 P、 gl、adioli。The taxonomic properties of this bacterium, which has the ability to produce the above-mentioned novel polygalactosamine-degrading enzyme, were
Of Deterministic Bacteriology” 8th edition (
1974) and Burgess Manual of Systematic Bacteriology, Volume 1 (1984).
In contrast to the classification of 2010), this bacterium does not require a gross factor, accumulates PH8, grows using arginine and betaine as sole carbon sources, is negative for arginine dehydrolase, negative for denitrification, and is grown at 40°C. From viable to section 2 (or ItNA group 2) P, cepac
ia, P, gl, adioli.
P、 marginateの類縁菌と思われるがP、
cepaciaとは硝酸塩の還元陽性、炭素源の資化性
ではD(−)−トレハロース、マルトース、ラクトース
、マレイン酸において異なる。P、 gladioli
とは、マル1へ一ス、ラフ1〜−ス、マレイン酸、m−
ハイドロキシブチル酸エステルの資化性の結果が異なる
。It seems to be a related bacterium of P. marginate, but P.
cepacia differs in nitrate reduction positivity and carbon source assimilation ability in D(-)-trehalose, maltose, lactose, and maleic acid. P. gladioli
means 1st square, 1st round, maleic acid, m-
The results of assimilation of hydroxybutyric acid ester are different.
P、 marginateとは、z−ハイドロキシブチ
ル酸エステルの結果が異なる。また、P、 cepac
ia、 P。The results for z-hydroxybutyric acid ester are different from P, marginate. Also, P, cepac
ia, P.
marginateは、非蛍光性色素を生成するが本菌
はKingB* F agar及びL−グルタミン酸、
L−アルギニン、し−スレオニン、L−ヒスチジンを唯
一の炭素源とした時弱い蛍光色素(青白蛍光)は生成す
るが非蛍光性色素の生成は種々の培地条件においても認
められない。これらの結果から、本菌はP。marginate produces a non-fluorescent dye, but this bacterium produces KingB* Fagar and L-glutamic acid,
When L-arginine, threonine, and L-histidine are used as the sole carbon source, a weak fluorescent dye (blue-white fluorescence) is produced, but no non-fluorescent dye is observed under various medium conditions. From these results, this bacterium is classified as P.
cepacia、 P、 gladioli、 P、
marginateとは異なる5peciasである・
本菌の生理学的諸性質で特徴的なことは、O−Fテスト
において単糖のみならずフル1−−ス、シュークロース
、ラクトース、セルビオースなどの二糖類からも酸を生
成することである。この性質はPseudomonas
属、低温性のP、 fragi、 p。cepacia, P. gladioli, P.
The physiological properties of this bacterium are different from the It is to produce acid. This property is similar to Pseudomonas
Genus, psychrotrophic P, fragi, p.
taetrolens(いずれもセクション5 )P、
1undensisと似ているが生育温度で違いがあ
る。taetrolens (both section 5) P,
It is similar to P. 1undensis, but there are differences in growth temperature.
以上の結果より本菌はPseudomonasの新菌種
と認められ、本菌をシュードモナスsp H881と命
名し、通商産業省工業技術院微生物工業技術研究所に、
微工研菌寄第8955号(FERM P−8955)と
して寄託されている。Based on the above results, this bacterium was recognized as a new species of Pseudomonas, and was named Pseudomonas sp H881.
It has been deposited as FERM P-8955.
ポリガラクトサミン分解酵素生産菌の培養培地としては
、炭素源、窒素源、無機物、その他の栄養素を程よく含
有する培地ならば、合成培地あるいは天然培地のいずれ
でも使用可能である。該培養培地の好適な例としては、
ポリガラクトサミン0.25%、グルコース0.25%
、酵母エキス0.05%。As a culture medium for polygalactosamine-degrading enzyme-producing bacteria, either a synthetic medium or a natural medium can be used as long as it contains a suitable amount of carbon sources, nitrogen sources, inorganic substances, and other nutrients. Suitable examples of the culture medium include:
Polygalactosamine 0.25%, glucose 0.25%
, yeast extract 0.05%.
ポリペプトン0.05%、pH7,0の例が挙げられる
。An example is polypeptone 0.05%, pH 7.0.
培養温度は20〜40℃、好ましくは30〜38℃の範
囲、培養開始pHは6〜8、好ましくは7付近で35〜
72時間振盪又は深部撹拌培養すれば、培養液中にポリ
ガラクトサミン分解酵素が得られる。そして、ボリガラ
ク1−サミン分解酵素は必要に応じて単離精製される。The culture temperature is in the range of 20 to 40°C, preferably 30 to 38°C, and the culture starting pH is 6 to 8, preferably around 7 and 35 to 38°C.
If the culture is performed with shaking or deep stirring for 72 hours, polygalactosamine-degrading enzyme can be obtained in the culture solution. Then, the borigalac 1-samine degrading enzyme is isolated and purified as necessary.
例えば、培養濾液をエタノール沈殿法によって粗酵素を
分離し、これを水性媒質に溶解し、セファデックスG−
50ゲル濾過、 CM−セファデックスC−25イオ
ン交換クロマトグラフイー、フェニル−セファロースC
L−4B疎水クロマトグラフィー等の処理により精製さ
れたポリガラクトサミン分解酵素が得られる。For example, the crude enzyme is separated from the culture filtrate by ethanol precipitation, dissolved in an aqueous medium, and Sephadex G-
50 gel filtration, CM-Sephadex C-25 ion exchange chromatography, phenyl-Sepharose C
A purified polygalactosamine degrading enzyme is obtained by treatment such as L-4B hydrophobic chromatography.
このようにして得た新規ポリガラクトサミン分解酵素を
、ポリガラクトサミンに作用させると、各種のガラクト
サミノオリゴ糖を効果的に得ることができる。この処理
は酵素を用いる加水分解の常法にしたがって行えばよく
、例えば次のような方法が例示される。When the novel polygalactosamine-degrading enzyme thus obtained is allowed to act on polygalactosamine, various galactosaminooligosaccharides can be effectively obtained. This treatment may be carried out according to a conventional method of hydrolysis using an enzyme, and examples thereof include the following method.
先ず、ポリガラクトサミンを低濃度の酸に溶解せしめる
。酸としては、例えば酢酸、ギ酸等の有機酸のほか、硫
酸を除く無機酸が広く使用できる。First, polygalactosamine is dissolved in a low concentration of acid. As the acid, in addition to organic acids such as acetic acid and formic acid, a wide range of inorganic acids other than sulfuric acid can be used.
こうして得られた多糖類溶液のpHを調整した後、上記
により調製したポリガラクトサミン分解酵素を加えて、
37℃前後の適温で酵素分解を行う。After adjusting the pH of the polysaccharide solution obtained in this way, the polygalactosamine degrading enzyme prepared above was added,
Enzymatic decomposition is performed at an appropriate temperature of around 37°C.
低分子の分解反応生成物を反応液から取り出し、これを
イオン交換樹脂に吸着せしめた後、適当な濃度勾配の溶
剤で溶出して、各種のガラクトサミノオリゴ糖両分を得
、これを精製して目的とするオリゴ糖をそれぞれ得るの
である。The low-molecular decomposition reaction product is removed from the reaction solution, adsorbed onto an ion exchange resin, and then eluted with a solvent with an appropriate concentration gradient to obtain various galactosaminooligosaccharide components, which are then purified. The desired oligosaccharides are then obtained.
既述したような酸又はアルカリ加水分解、あるいは酵素
分解を単独でまたはこれらを適宜組合わせることによっ
て、目的とするガラクトサミノオリゴ糖を単独で又は混
合物として得ることができる。即ち、上記によりポリガ
ラクトサミンを加水分解すれば、極めて効果的に、ガラ
クトサミンオリゴ−2糖〜12糖をそれぞれ得ることが
できるし、必要な場合には各オリゴ糖の適宜の混合物も
自由に得ることができるのである。The target galactosaminooligosaccharide can be obtained alone or as a mixture by acid or alkaline hydrolysis or enzymatic decomposition as described above, alone or in an appropriate combination. That is, by hydrolyzing polygalactosamine as described above, each of galactosamine oligo-disaccharides to dodecaccharides can be obtained extremely effectively, and if necessary, an appropriate mixture of each oligosaccharide can also be freely obtained. This is possible.
このようにして得られた少糖類は、IIPLC,TLC
等の標準品として利用できるほか、キチン、キトサンの
オリゴマーと同様な又は異なった生理活性が期待され、
例えば抗腫瘍活性が特に有望であるところから、各種の
医薬として又はその原料ないし中間体としても利用する
ことができる。The oligosaccharide obtained in this way was analyzed by IIPLC, TLC.
It can be used as a standard product such as chitin and chitosan oligomers, and is expected to have similar or different physiological activity to chitin and chitosan oligomers.
For example, since it has particularly promising antitumor activity, it can be used as a variety of pharmaceuticals or as raw materials or intermediates thereof.
抗腫瘍活性は、各オリゴ糖単独で期待されるばかりでな
く、オリゴ糖混合物(例えば3糖、4糖。Antitumor activity is expected not only for each oligosaccharide alone, but also for oligosaccharide mixtures (e.g., trisaccharides, tetrasaccharides).
5糖の混合物)とした方が更に強力な抗腫瘍活性が期待
できる場合もあり、いずれにせよ、本発明に係るオリゴ
糖は抗腫瘍剤として利用することが可能である。また、
食品添加物、栄養剤、保健剤、農薬、工業薬品としても
利用可能である。In some cases, even stronger antitumor activity can be expected if the oligosaccharide is a mixture of pentasaccharides), and in any case, the oligosaccharide according to the present invention can be used as an antitumor agent. Also,
It can also be used as a food additive, nutritional supplement, health agent, agricultural chemical, and industrial chemical.
次に本発明の実施例を示す。Next, examples of the present invention will be shown.
実施例1
ポリガラクトサミンの調製
グルコース600g、ポリペプトン60g、CaC1□
・2t(20125gを水道水17Qに溶解し、′aN
aol+溶液でρ117.0に調整した後30Q容ジャ
ーファーメンタ−に移した。Example 1 Preparation of polygalactosamine 600 g of glucose, 60 g of polypeptone, 1□ CaC
・2t (20125g dissolved in 17Q tap water, 'aN
After adjusting to ρ117.0 with aol+ solution, it was transferred to a 30Q jar fermenter.
この培地溶液に蒸気を注入することにより加圧。Pressurize this medium solution by injecting steam.
加熱滅菌(121℃、20分間)を行った。冷却後の培
地(最終液量20Q)に、500n+12三角フラスコ
に150+nR同組成の培地(グルコース3%、ポリペ
プトン0.3%、CaC1,0,5%、p)17.0)
で26℃、4日間振盪培養したベニシロマイセスI −
I F[ERM P−3928(FERMBP−118
0)を容量比で約10%無菌的に接種した。接種後27
℃、通気量0.5VVM、撹拌数20ORPM ノ条件
で5日間培養した。Heat sterilization (121°C, 20 minutes) was performed. Add 150+nR to the cooled medium (final liquid volume 20Q) in a 500n+12 Erlenmeyer flask (3% glucose, 0.3% polypeptone, 17.0% CaCl, 0.5%, p)
Benicillomyces I − was cultured with shaking at 26°C for 4 days.
IF[ERM P-3928 (FERMBP-118
0) was aseptically inoculated at a volume ratio of approximately 10%. 27 days after vaccination
The cells were cultured for 5 days under the following conditions: °C, aeration rate of 0.5 VVM, and agitation number of 20 ORPM.
培養終了後培養物を濾布濾過することにより培養濾液i
nを得た。この培養濾液を50℃〜60°Cに加熱しな
がら分画分子量16万の限外濾過膜(三菱レイヨン・エ
ンジニアリング社製UF膜チューブラ−モジュールFタ
イプ)を通過させることにより、低分子画分を除き液量
が約30になる迄濃縮した。更に、約1.4000XG
で遠心分離することにより菌体残渣、熱変性蛋白質を除
去した。After the culture is completed, culture filtrate i is obtained by filtering the culture with a filter cloth.
I got n. This culture filtrate was heated to 50°C to 60°C and passed through an ultrafiltration membrane with a molecular weight cutoff of 160,000 (UF membrane tubular module F type manufactured by Mitsubishi Rayon Engineering Co., Ltd.) to remove the low molecular fraction. It was concentrated until the volume of the removed liquid was about 30%. Furthermore, about 1.4000XG
Cell residue and heat-denatured proteins were removed by centrifugation.
遠心分離後に上澄液画分3Qに食塩約750 g (約
25%濃度)を加え攪拌し、溶解後、濃NaOHでpl
+を7.0〜8.5に調整した。−夜放置し塩析物を十
分析出させた後、サラン製の布(塩化ビニリデンと塩化
ビニールの共重合体)上に塩析物を回収した。After centrifugation, approximately 750 g of common salt (approximately 25% concentration) was added to supernatant fraction 3Q, stirred, dissolved, and plipped with concentrated NaOH.
+ was adjusted to 7.0 to 8.5. - The salted-out material was left to stand overnight, and the salted-out material was collected on Saran cloth (copolymer of vinylidene chloride and vinyl chloride).
更にこの塩析物の上から大量の微アルカリ性の水(pH
7,0以上)を撒布することにより余分の食塩及び培養
液に同時に混在している中性糖、その他の夾雑物を洗い
流した。Furthermore, a large amount of slightly alkaline water (pH
7.0 or more) to wash away excess common salt, neutral sugars, and other impurities mixed in the culture solution at the same time.
次に、水洗後の塩析物に0.1M塩酸溶液を容量比で約
3倍量加え溶解した。この溶解物に濃NaOH溶液を加
えポリガラクトサミンの等電点であるpl+8.5に合
せた。−夜放置し十分析出物を析出させた後、上記と同
様サラン製の布上に析出物を回収し、大量の水道水で洗
った。この水洗物をもう1度0.1M塩酸に溶解後、等
電点沈澱を行い水洗を繰返すことにより精製した。Next, approximately three times the volume of 0.1M hydrochloric acid solution was added to the salted out product after washing with water and dissolved. A concentrated NaOH solution was added to this lysate to adjust it to pl+8.5, which is the isoelectric point of polygalactosamine. - After leaving it overnight to precipitate the ten-analyte precipitate, the precipitate was collected on a saran cloth in the same manner as above and washed with a large amount of tap water. This washed product was dissolved once again in 0.1M hydrochloric acid, subjected to isoelectric precipitation, and purified by repeated washing with water.
この精製した析出物を121℃、15分間滅菌後、凍結
乾燥することにより、ポリガラクトサミンを主成分とす
るPF−102の精製粉末(ポリガラクトサミンとして
の純度約99%)を7g得た。The purified precipitate was sterilized at 121° C. for 15 minutes and then freeze-dried to obtain 7 g of purified powder of PF-102 containing polygalactosamine as a main component (about 99% purity as polygalactosamine).
また、用途により上記精製粉末の1部を0.1M塩酸に
溶解し分画分子量30万の限外濾過膜(アミコン社製分
子篩膜タイプXM 300)で分画し、平均分子量16
〜30万のものと平均分子量30万以上のものに分画す
ることもできる。Depending on the purpose, a part of the above purified powder is dissolved in 0.1M hydrochloric acid and fractionated using an ultrafiltration membrane with a molecular weight cutoff of 300,000 (Molecular Sieve Membrane Type XM 300 manufactured by Amicon), with an average molecular weight of 16
It can also be fractionated into those with an average molecular weight of ~300,000 and those with an average molecular weight of 300,000 or more.
実施例2
ガラクトサミノオリゴ糖の調製
精製ポリ−ガラクトサミン(PF102) 100gを
4規定塩酸、2Qに分散させ、冷却管付き三角フラスコ
中にて、80℃、8時間、塩酸加水分解した。Example 2 Preparation of galactosaminooligosaccharide 100 g of purified poly-galactosamine (PF102) was dispersed in 4N hydrochloric acid, 2Q, and hydrochloric acid hydrolyzed at 80° C. for 8 hours in an Erlenmeyer flask equipped with a cooling tube.
分解後、この塩酸溶液を濾紙濾過して未分解残渣を除去
し、これに活性炭約100gを加えて脱色した。次に、
陰イオン交換樹脂AG3X4A (米国バイオ−ラッド
社製)を充填したカラム(8X 75c+++)にこの
溶液を通過させ、塩酸を除去した。After decomposition, the hydrochloric acid solution was filtered through a filter paper to remove undecomposed residues, and about 100 g of activated carbon was added to decolorize the solution. next,
This solution was passed through a column (8X 75c+++) packed with anion exchange resin AG3X4A (manufactured by Bio-Rad, USA) to remove hydrochloric acid.
次いで、得られたガラクトサミノオリゴ糖混液を活性化
してカラムに充填したい一セファデックスC−25(2
,5X 100cI11)に吸着させ充分水洗後、O〜
2.5モル食塩による直線的濃度勾配で溶出させ、その
結果、12のピークを分画した(第1図)。なおこの場
合、ΔOD、=2nmはインドール塩酸法によるガラク
トサミンの測定結果である。Next, the obtained galactosaminooligosaccharide mixture is activated and packed into a column using Sephadex C-25 (2
, 5X 100cI11) and after thorough washing with water, O ~
It was eluted with a linear concentration gradient of 2.5M NaCl, resulting in the fractionation of 12 peaks (Figure 1). In this case, ΔOD=2 nm is the measurement result of galactosamine by the indole-hydrochloric acid method.
得られた各ピークのガラクトサミノオリゴ糖を再度活性
炭により脱色し1重合度n < 4にあっては電気透析
機、ミクロ アシライザーG−1100(旭化成社製)
で脱塩し、吸引濃縮液後、凍結乾燥して、また重合度3
< nにあっては限外濾過膜(Ul+−05ウルトラ
フィルターアトバンチツク1−−ヨー社製)にて脱塩、
濃縮し、凍結乾燥して各両分のガラ91へサミノオリゴ
糖を得た。この時、得られた各両分の回収量は第1表に
示した。The obtained galactosaminooligosaccharide of each peak was decolorized again with activated carbon, and if the degree of polymerization n < 4, it was decolorized using an electrodialysis machine and Micro Asylyzer G-1100 (manufactured by Asahi Kasei Corporation).
After desalting with
<n, desalt with an ultrafiltration membrane (Ul+-05 Ultrafilter Atovanchik 1-Yo Co., Ltd.),
It was concentrated and freeze-dried to obtain both gala-91 saminooligosaccharides. At this time, the recovered amounts of each of the two portions obtained are shown in Table 1.
また、得られた各ガラクトサミノオリゴ糖の各旋光度を
測定したところそれらの旋光度と重合度との間に第2図
の関係が成り立ち、各両分はガラクトサミノオリゴ糖が
重合度の小さい順に順次溶出されていることが分かった
。すなわち、第2図はガラクトサミノオリゴ糖の分子旋
光度と重合度との関係を表わしたグラフであって、比旋
光度〔α〕Dと分子量との積が分子旋光度CM)nであ
り。In addition, when the optical rotations of each of the obtained galactosaminooligosaccharides were measured, the relationship shown in Figure 2 was established between the optical rotations and the degree of polymerization. It was found that they were eluted sequentially in ascending order of size. That is, FIG. 2 is a graph showing the relationship between the molecular optical rotation and the degree of polymerization of galactosaminooligosaccharides, where the product of the specific optical rotation [α]D and the molecular weight is the molecular optical rotation CM)n. .
(M)n/nと(n−1)/nとは直線関係が成立する
ことを示している(nは重合度を表わす)。(M)n/n and (n-1)/n have a linear relationship (n represents the degree of polymerization).
第1表
両分 溶出食塩濃度(モル) ガラクトサミノオリゴ糖
(g)1 0.27 11
.92 0.48 9.73
0.73 6.24
0.94 5.75 1
.16 3.66 1.3
3 3.07 1.58
2.38 1.73
2.19 1.86
1.610 1.99
1.111 2.10
1.012 2.22
0.8実施例3
ポリガラクトサミン分解酵素の調製
シュードモナスsp 8881. FERM P−89
55を500m12三角フラスコ中で、グルコース0.
5%、酵母エキス0.05%、ポリペプトン0.05%
の組成を有する種培地100mρに植菌し、30℃で2
0時間培養する。Both parts of Table 1 Dissolved salt concentration (mol) Galactosaminooligosaccharide (g) 1 0.27 11
.. 92 0.48 9.73
0.73 6.24
0.94 5.75 1
.. 16 3.66 1.3
3 3.07 1.58
2.38 1.73
2.19 1.86
1.610 1.99
1.111 2.10
1.012 2.22
0.8 Example 3 Preparation of polygalactosamine degrading enzyme Pseudomonas sp 8881. FERM P-89
55 in a 500 m 12 Erlenmeyer flask with 0.5 g of glucose.
5%, yeast extract 0.05%, polypeptone 0.05%
Inoculate 100 mρ of seed medium with the composition of
Incubate for 0 hours.
得られた種培養液を30Ωのジャーファーメンタ−中で
、ポリガラクトサミン(PF−102)0.25%、グ
ルコース0.25%、酵母エキス0.05%、ポリペプ
トン0.05%の酵素生産培地18Qに植菌し、30℃
で通気量I VVM、攪拌数20ORPMで48時間培
養した。The obtained seed culture solution was placed in a 30Ω jar fermentor and added to an enzyme production medium containing 0.25% polygalactosamine (PF-102), 0.25% glucose, 0.05% yeast extract, and 0.05% polypeptone. Inoculated on 18Q and heated to 30℃
The cells were cultured for 48 hours at an aeration rate of IVVM and a stirring rate of 20 ORPM.
得られた培養液を遠心分離(14,OOOrpm) I
、て、菌体を除き、得られた培養濾液に冷却したエタノ
ールを60%濃度まで加えて、タンパク質を沈殿させ、
この沈殿タンパク質を遠心して、溶液から分離する。得
られたタンパク質を0.1モル酢酸緩衝液(pH5,0
)で平衡化したCトセファデックスC−25カラム(2
、5X 60cm)に吸着させ、O−0,5モル食塩の
濃度勾配を有する同緩衝液を用いて溶出させる。Centrifuge the obtained culture solution (14, OOOrpm) I
, remove the bacterial cells, add cooled ethanol to the obtained culture filtrate to a concentration of 60%, and precipitate the protein.
The precipitated protein is separated from the solution by centrifugation. The obtained protein was dissolved in 0.1 molar acetate buffer (pH 5,0
) equilibrated with a C tosephadex C-25 column (2
, 5×60 cm) and eluted using the same buffer with a gradient of O-0.5 molar saline.
溶出した酵素活性区分を集め、限外濾過装置(分画分子
量1万)を使って濃縮する。次に、2モル食塩を含む0
.1モル酢酸緩衝液(pH6、0)溶液とし、同緩衝液
で平衡化したセファデックスG−50カラム(5X 9
0cm)クロマトグラフィーにかける。次いで。The eluted enzyme activity fraction is collected and concentrated using an ultrafiltration device (molecular weight cut off: 10,000). Next, 0 containing 2 molar salt
.. A Sephadex G-50 column (5X 9
0 cm) chromatography. Next.
活性区分の食塩濃度を4モルにまで高め、同様な溶液で
平衡化したフェニル−セファロースCL−4Bカラム(
2,5X 20cm)に吸着させ1食塩の逆濃度勾配を
持つ0.1モル酢酸緩衝液で溶出して精製ポリガラクト
サミン分解酸!50mg (収率23.1%、比活性5
2μg galN/min/mg protein)を
得る。A phenyl-Sepharose CL-4B column equilibrated with the same solution with the salt concentration in the active section increased to 4 molar (
2,5X 20cm) and eluted with 0.1M acetate buffer with an inverse concentration gradient of 1 NaCl to purified polygalactosamine decomposed acid! 50 mg (yield 23.1%, specific activity 5
2 μg galN/min/mg protein).
実施例4
ガラクトサミノオリゴ糖の調製
〈酵素分解−囲セファデックスC−25クロマト〉精製
ポリガラクトサミン25gを約4.8Qの0.1モル酢
酸に溶解し1次いで水酸化ナトリュウムでPH6,0に
調製して水を加えて全液量を5Qとした。Example 4 Preparation of galactosaminooligosaccharides (enzymatic degradation - Sephadex C-25 chromatography) 25 g of purified polygalactosamine was dissolved in 0.1 molar acetic acid of about 4.8 Q, and then adjusted to pH 6.0 with sodium hydroxide. The total liquid volume was adjusted to 5Q by adding water.
このポリガラクトサミン溶液を基質とし、精製ポリガラ
クトサミン分解酵素5mg(約500ユニツト)(本1
ユニツトは1分間にガラクトサミン1μモル精製する酵
素力価)を加え37℃で1時間酵素分解した。Using this polygalactosamine solution as a substrate, 5 mg (approximately 500 units) of purified polygalactosamine degrading enzyme (book 1)
The unit was enzymatically decomposed at 37°C for 1 hour by adding an enzyme titer capable of purifying 1 μmol of galactosamine per minute.
分解後、100℃、10分間加熱して酵素反応を止め、
不溶物を遠心して除いた。次いで、得られた溶液のPH
を酢酸を用いて5.0に調整し、弱陽イオン交換体Cト
セファデックスC−25カラム(2X 40co+)に
吸着させた。After decomposition, heat at 100℃ for 10 minutes to stop the enzyme reaction.
Insoluble matter was removed by centrifugation. Then, the pH of the obtained solution
was adjusted to 5.0 using acetic acid and adsorbed onto a weak cation exchanger C Tosephadex C-25 column (2X 40co+).
この方ラムを0.1モル酢酸緩衝液(pH5,0)で洗
浄後、0〜2.5モルの食塩による直線的濃度勾配で溶
出させ、単離される各両分を集めた。After washing the column with 0.1 molar acetate buffer (pH 5.0), it was eluted with a linear concentration gradient of 0 to 2.5 molar sodium chloride, and both isolated fractions were collected.
各両分は電気透析機、マイクロ・アシライザーG3(旭
化成社製)にて脱塩し、凍結乾燥して精製ガラクトサミ
ノオリゴ糖とした。Both portions were desalted using an electrodialysis machine, Micro Acylyzer G3 (manufactured by Asahi Kasei Corporation), and freeze-dried to obtain purified galactosaminooligosaccharides.
この時、得られた各両分の回収量は表−2に示した。At this time, the amounts recovered for each portion are shown in Table 2.
第 2 表
(ガラクトサミノオリゴ糖)(g)
ガラクトサミン 0.18ガラクトサ
ミノオリゴー29 0.36ガラクトサミノオリゴー
39 1.80ガラクトサミノオリゴ−4糖 1
.65ガラクトサミノオリゴー5糖 1.20ガラク
トサミノオリゴー6糖 0.84ガラクトサミノオリ
ゴー7糖 0.60ガラクトサミノオリゴー8糖
0.48ガラクトサミノオリゴー9糖 0.39ガラ
グトサミノオリゴ−10糖0.24ガラクトサミノオリ
ゴー11&lf O,18ガラクトサミノオリゴ−
12糖 0.12実施例5
ガラクトサミノオリゴ糖の調整
〈酵素分解−Dowex50W X 8クロマト〉精製
ポリガラクトサミン25gを約4.8Qの0.1モル酢
酸に溶解し1次に、水酸化ナトリウムでρ116.0に
調整し、全液量を5Qとした。このポリガラクトサミン
溶液を基質とし、これに精製したポリガラクトサミン分
解酵素10mg(約1000ユニツト *1ユニットは
1分間にガラクトサミン1μモルを生成する酵素力価)
を加え37℃で酵素分解した。Table 2 (Galactosaminooligosaccharide) (g) Galactosamine 0.18 Galactosaminoligo 29 0.36 Galactosaminoligo 39 1.80 Galactosaminooligo-tetrasaccharide 1
.. 65 galactosaminoligo pentasaccharide 1.20 galactosaminoligo hexasaccharide 0.84 galactosaminoligo heptasaccharide 0.60 galactosaminoligo octasaccharide
0.48 Galactosaminoligo 9-saccharide 0.39 Galactosaminoligo-10saccharide 0.24 Galactosaminoligo 11&lf O,18 Galactosaminoligo-
12-saccharide 0.12 Example 5 Preparation of galactosamino-oligosaccharides (enzymatic degradation - Dowex 50W It was adjusted to ρ116.0, and the total liquid volume was 5Q. Using this polygalactosamine solution as a substrate, 10 mg of purified polygalactosamine-degrading enzyme (approximately 1000 units *1 unit is the enzyme titer that produces 1 μmol of galactosamine per minute)
was added and enzymatically decomposed at 37°C.
分子量3000以下の分解反応生成物はホローファイバ
ーHIP−3(アミコン・ファー・イースト・リミテッ
ド社製、DC−2型ホローフアイバー)を用いて連続的
に反応液から取り出し、直接陽イオン交換樹脂ダペック
ス501i1 X 8 (2,5X 50cm)に吸着
させた。Decomposition reaction products with a molecular weight of 3000 or less are continuously removed from the reaction solution using a hollow fiber HIP-3 (manufactured by Amicon Far East Ltd., DC-2 type hollow fiber) and directly transferred to a cation exchange resin DAPEX 501i1. It was adsorbed onto X 8 (2.5X 50cm).
ダペックス50W x 8からのガラクトサミノオリゴ
糖の溶出は0〜4モルの塩酸濃度勾配によって行った。Elution of galactosaminooligosaccharides from DAPEX 50W x 8 was performed with a 0-4 molar hydrochloric acid concentration gradient.
次いで、得られる各ガラクトサミノオリゴ糖溶液は陰イ
オン交換樹脂CDR2O(三菱化成製)で処理し、塩酸
を除いた。この溶液を凍結乾燥して精製ガラクトサミノ
オリゴ糖を得た。得られた各ガラクトサミノオリゴ糖量
は第3表に示した。Next, each of the resulting galactosaminooligosaccharide solutions was treated with an anion exchange resin CDR2O (manufactured by Mitsubishi Kasei) to remove hydrochloric acid. This solution was freeze-dried to obtain a purified galactosaminooligosaccharide. The amounts of each galactosaminooligosaccharide obtained are shown in Table 3.
第3表
(ガラクトサミノオリゴ糖)(g)
ガラクトサミン 0.8ガラクトサミ
ノオリゴー2糖 1.6ガラクトサミノオリゴー3
&!7.0
ガラクトサミノオリゴー4糖 4.0ガラクトサミ
ノオリゴー5糖 3.0ガラクトサミノオリゴ−6
糖 1.2実施例6
ガラクトサミノオリゴ糖の調整
〈塩酸分解−Dowex501i1 X 8クロマト〉
精製ポリガラク1−サミン25gを濃塩酸(12規定)
250mQに分散し、80℃、4時間、加水分解した。Table 3 (Galactosaminooligosaccharide) (g) Galactosamine 0.8 Galactosaminoligo disaccharide 1.6 Galactosaminoligo 3
&! 7.0 Galactosaminooligotetrasaccharide 4.0 Galactosaminoligopentasaccharide 3.0 Galactosaminoligo-6
Sugar 1.2 Example 6 Preparation of galactosaminooligosaccharide <Hydrochloric acid decomposition - Dowex 501i1 X 8 chromatography>
25g of purified polygalac 1-samine in concentrated hydrochloric acid (12N)
It was dispersed in 250 mQ and hydrolyzed at 80°C for 4 hours.
次いで、この溶液を減圧濃縮して、塩酸を除去し、ダペ
ックス50W X 8 (2,5X 50cm)のカラ
ムクロマトグラフィー(0〜5モルの塩酸濃度勾配で溶
出)を行いガラクトサミノオリゴ糖を分離精製した。Next, this solution was concentrated under reduced pressure to remove hydrochloric acid, and the galactosaminooligosaccharide was separated by column chromatography on Dapex 50W x 8 (2.5 x 50 cm) (eluted with a 0-5 molar hydrochloric acid concentration gradient). Purified.
精製した各ガラクトサミノオリゴ糖はAG3X4Aで処
理して塩酸を除去した後、凍結乾燥して精製ガラクトサ
ミノオリゴ糖を得た。Each purified galactosaminooligosaccharide was treated with AG3X4A to remove hydrochloric acid, and then lyophilized to obtain a purified galactosaminooligosaccharide.
結果を第4表に示した。The results are shown in Table 4.
第4表
(ガラクトサミノオリゴM) (g)ガラク
トサミン 8.0ガラクトサミノオリ
ゴー2糖 6.0ガラクトサミノオリゴー3糖
4.0ガラクトサミノオリゴー4糖 2.0ガラ
クトサミノオリゴー5糖 1.0ガラクトサミノオ
リゴー6糖 0.8このようにしてガラクトサミノ
オリゴ糖が得られたが、これらはいずれも新規物質であ
り、ガラクトサミンオリゴ−2l11Ili〜12糖の
物性は以下に示すとおりである。Table 4 (Galactosaminoligo M) (g) Galactosamine 8.0 Galactosaminoligo disaccharide 6.0 Galactosaminoligo trisaccharide
4.0 Galactosaminoligotetrasaccharide 2.0 Galactosaminoligopentasaccharide 1.0 Galactosaminoligohexasaccharide 0.8 Galactosaminoligosaccharides were obtained in this way, but these are all new. The physical properties of galactosamine oligo-2l11Ili-12-12 are as shown below.
■、物質の名称:ガラクトサミンオリゴ−2糖1)α−
1→4結合のみで構成されるガラクトサミンの2糖
Ga1N1−+、Ga1N(但し、Ga1Nはa−D−
ガラクトサミノピラノシル基を示す。)
2)色および形状:淡黄色不定形の粉末3)味:甘味を
有する。■, Name of substance: Galactosamine oligo-disaccharide 1) α-
Galactosamine disaccharides composed of only 1→4 bonds Ga1N1-+, Ga1N (however, Ga1N is a-D-
Indicates a galactosaminopyranosyl group. ) 2) Color and shape: Pale yellow amorphous powder 3) Taste: Sweet taste.
4)溶解性:薄い酸(塩酸などの鉱酸あるいは蟻酸や酢
酸などの有機酸など)、塩化ナトリウム、塩化カリウム
などの塩の水溶液および水にそれぞれ可溶であり、ジメ
チルスルホオキシドを除く一般的な有機溶媒(メタノー
ル、エタノール、アセトン、クロロホルムなど)に難溶
性である。4) Solubility: Soluble in dilute acids (mineral acids such as hydrochloric acid or organic acids such as formic acid and acetic acid), aqueous solutions of salts such as sodium chloride, potassium chloride, and water, and common acids except dimethyl sulfoxide. It is sparingly soluble in organic solvents (methanol, ethanol, acetone, chloroform, etc.).
5)下記の元素分析値を示す。5) Show the following elemental analysis values.
C: 42.35、H: 7.06、N : 8.24
、O: 42.35予想される分子式:C1□1(24
0’JN26)分子量と構造式は下記の通り。C: 42.35, H: 7.06, N: 8.24
, O: 42.35 Expected molecular formula: C1□1(24
0'JN26) The molecular weight and structural formula are as follows.
分子量: 340.2 7)下記の呈色反応を示す。Molecular weight: 340.2 7) Show the following color reaction.
インドール塩酸反応、エルソンーモルガン反応、ソモギ
ーネルソン反応にそれぞれ陽性、モルガンー二ルソン反
応、ローリ−・フォーリン反応に僅かに陽性、フェノー
ル硫酸反応、ヨード反応に陰性。Positive for indole-hydrochloric acid reaction, Elson-Morgan reaction, Somogyy-Nelson reaction, slightly positive for Morgan-Nilson reaction, Lowry-Forin reaction, negative for phenol-sulfuric acid reaction, and iodine reaction.
8)旋光度 〔α〕ら’ : +127.4 9)融点 164℃ 1.0)第3図に紫外部吸収スペクトルを示す。8) Optical rotation [α] et al’: +127.4 9) Melting point 164℃ 1.0) Figure 3 shows the ultraviolet absorption spectrum.
11)第4図に赤外部吸収スペクトルを示す。11) Figure 4 shows the infrared absorption spectrum.
2、 物質の名称:ガラクトサミンオリゴ−3糖1)α
−1→4結合のみで構成されるガラクトサミンの3糖
Ga1N1−)4GalN、−)4GalN(但し、G
a1Nはa−D−ガラクトサミノピラノシル基を示す。2. Name of substance: Galactosamine oligo-trisaccharide 1) α
Galactosamine trisaccharide Ga1N1-)4GalN, -)4GalN (however, G
a1N represents a-D-galactosaminopyranosyl group.
) 2)色と形状二同上 3)味:弱い甘味を呈する。) 2) Color and shape 2 ditto 3) Taste: Has a weak sweet taste.
4)溶解性二同上 5)下記の元素分析値を示す。4) Solubility 2 ditto 5) Show the following elemental analysis values.
C: 43.11. H: 6.99、N : 8.3
8、O: 41.52予想される分子式:C1,H35
0□3Nff6)分子量と構造式は下記の通り。C: 43.11. H: 6.99, N: 8.3
8, O: 41.52 Expected molecular formula: C1, H35
0□3Nff6) The molecular weight and structural formula are as follows.
分子lit: 501.3 7)呈色反応:同上 8)旋光度 〔α〕♂’ : +158.3 9)融点 特定の融点を有さす。160℃以上で炭化を始める。Molecule lit: 501.3 7) Color reaction: same as above 8) Optical rotation [α]♂’: +158.3 9) Melting point It has a specific melting point. Carbonization begins at 160°C or higher.
10)第5図に紫外部吸収スペクトルを示す。10) Figure 5 shows the ultraviolet absorption spectrum.
11)第6図に赤外部吸収スペクトルを示す。11) Figure 6 shows the infrared absorption spectrum.
3、物質の名称:ガラクトサミンオリゴ−4糖1)α−
1→4結合のみで構成されるガラクトサミンの4糖
Ga1N1−+、Ga1N1−+4GalN1−+4G
alN (但し、Ga1Nはα−D−ガラクトピラノシ
ル基を示す。)2)色と形状:同上
3)味:僅かな甘味を有する。3. Name of substance: Galactosamine oligo-tetrasaccharide 1) α-
Galactosamine tetrasaccharide Ga1N1-+, Ga1N1-+4GalN1-+4G composed of only 1→4 bonds
alN (However, Ga1N represents an α-D-galactopyranosyl group.) 2) Color and shape: Same as above 3) Taste: Has a slight sweetness.
4)溶解性:同上 5)下記の元素分析値を示す。4) Solubility: Same as above 5) Show the following elemental analysis values.
C: 43.50、H: 6.95、N : 8.46
、O: 41.09予想される分子式: C24H,,
0,□N46)分子量と構造式は下記の通り。C: 43.50, H: 6.95, N: 8.46
, O: 41.09 Expected molecular formula: C24H,,
0,□N46) The molecular weight and structural formula are as follows.
分子量: 662.4
■)α−1→4結合のみで構成されるガラクトサミンの
5糖
Ga1N、−+4GalN1−+4GalN、−+40
a1.N□−+40alN (但し、Ga INはα−
0−ガラクトピラノシル基を示す。)
色と形状二同上
味:弱い甘味を有する。Molecular weight: 662.4 ■) Galactosamine pentasaccharide composed of only α-1 → 4 bonds Ga1N, -+4GalN1-+4GalN, -+40
a1. N□-+40alN (However, Ga IN is α-
Indicates 0-galactopyranosyl group. ) Color and shape Taste: Has a weak sweet taste.
溶解性:同上 7)呈色反応二同上 8)旋光度 〔α〕♂’ : +174.1 9)融点:同上 10)第7図に紫外部吸収スペクトルを示す。Solubility: Same as above 7) Color reaction 2 ditto 8) Optical rotation [α]♂’: +174.1 9) Melting point: same as above 10) Figure 7 shows the ultraviolet absorption spectrum.
11)第8図に赤外部吸収スペクトルを示す。11) Figure 8 shows the infrared absorption spectrum.
4、物質の名称:ガラクトサミンオリゴ−5糖C: 4
3.74、H: 6.93.N : 8.51、O:
40.83予想される分子式: C3o Hs 702
tNs6)分子量と構造式は下記の通り。4. Name of substance: Galactosamine oligo-pentasaccharide C: 4
3.74, H: 6.93. N: 8.51, O:
40.83 Expected molecular formula: C3o Hs 702
tNs6) The molecular weight and structural formula are as follows.
分子+ii : 823.4 7)呈色反応:同上 8)旋光度 〔α〕′D。: +183.8 融点:同上 第9図に紫外部吸収スペクトルを示す。Molecule +ii: 823.4 7) Color reaction: same as above 8) Optical rotation [α]′D. : +183.8 Melting point: Same as above FIG. 9 shows the ultraviolet absorption spectrum.
第10図に赤外部吸収スペクトルを示す。Figure 10 shows the infrared absorption spectrum.
物質の名称:ガラクトサミンオリゴ−6糖α−1→4結
合のみで構成されるガラクトサミンの6糖
Ga1N、→4calN工→4GaIN□→4GaIN
工→4GaIN1→、Ga1N (但し、Ga1Nはa
−D−ガラクトピラノシル基を示す。)
色と形状:同上
味:同上
溶解性:同上
下記の元素分析値を示す。Name of substance: Galactosamine oligo-hexasaccharide α-1→4-linked galactosamine hexasaccharide Ga1N → 4calN → 4GaIN□ → 4GaIN
Engineering→4GaIN1→, Ga1N (However, Ga1N is a
-D-Galactopyranosyl group. ) Color and shape: Same as above Taste: Same as above Solubility: Same as above The following elemental analysis values are shown.
C: 43.90、H: 6.91. N : 8.5
4、○: 40.65予想される分子式’ c、 a
o68 o、、5 NG6)分子量と構造式は下記の通
り。C: 43.90, H: 6.91. N: 8.5
4, ○: 40.65 Expected molecular formula' c, a
o68 o,,5 NG6) The molecular weight and structural formula are as follows.
分子量: 984.6 7)呈色反応:同上 8)旋光度 〔α〕も’ : +190.2 融点:同上 第11図に紫外部吸収スペクトルを示す。Molecular weight: 984.6 7) Color reaction: same as above 8) Optical rotation [α] too’: +190.2 Melting point: Same as above FIG. 11 shows the ultraviolet absorption spectrum.
第12図に赤外部数スペクトルを示す。Figure 12 shows the infrared number spectrum.
物質の名称:ガラクトサミノオリゴー7糖α−1→4結
合のみで構成されるガラクトサミンの7糖
Ga1N、 −+4GalN1−+4GalN1−+、
Ga1N1→4GalN□−+、Ga1N、 −+4G
alN
2)色と形状二同上
3)味:同上
4)溶解性:同上
5)下記の元素分析値を示す。Name of substance: Galactosamine oligosaccharide consisting only of α-1→4 bonds GalN, -+4GalN1-+4GalN1-+,
Ga1N1→4GalN□-+, Ga1N, -+4G
alN 2) Color and shape 2) Same as above 3) Taste: Same as above 4) Solubility: Same as above 5) The following elemental analysis values are shown.
C: 44.02、H: 6.90、N : 8.56
、O: 40.52予想される分子式二C4□H7,0
□9N?6)分子量と構造式は下記の通り。C: 44.02, H: 6.90, N: 8.56
, O: 40.52 Expected molecular formula 2C4□H7,0
□9N? 6) The molecular weight and structural formula are as follows.
分子ffi : 1145.7
GalN1+、Ga1N、→−,Ga lN2)色と形
状二同上
3)味:同上
4)溶解性:同上
5)下記の元素分析値を示す。Molecule ffi: 1145.7 GalN1+, Ga1N, →-, GalN2) Color and shape 2 Same as above 3) Taste: Same as above 4) Solubility: Same as above 5) The following elemental analysis values are shown.
C: 44.10、H: 6.89、N : 8.58
.0 : 40.43予想される分子式: C45Hs
oOizNs6)分子量と構造式は下記の通り。C: 44.10, H: 6.89, N: 8.58
.. 0: 40.43 Expected molecular formula: C45Hs
oOizNs6) The molecular weight and structural formula are as follows.
分子量: 1306.8 7)呈色反応:同上 8)旋光度 〔α〕も’ : +194.9 融点二同上 第13図に紫外熱吸収スペクトルを示す。Molecular weight: 1306.8 7) Color reaction: same as above 8) Optical rotation [α] too’: +194.9 melting point 2 ditto FIG. 13 shows the ultraviolet thermal absorption spectrum.
第14図に赤外部吸収スペクトルを示す。FIG. 14 shows the infrared absorption spectrum.
物質の名称:ガラクトサミンオリゴ−8&fα−1→4
結合のみで構成されるガラクトサミンの8M
7)呈色反応二同上
8)旋光度
〔α〕も’ : +198.5
9)融点:同上
10)第15図に紫外熱吸収スペクトルを示す。Name of substance: Galactosamine oligo-8 & fα-1→4
8M of galactosamine composed only of bonds 7) Color reaction 2 ditto above 8) Optical rotation [α] also ': +198.5 9) Melting point: ditto 10) Figure 15 shows the ultraviolet heat absorption spectrum.
11)第16図に赤外部吸収スペクI−ルを示す。11) Figure 16 shows the infrared absorption spectrum.
8、物質の名称:ガラクトサミノオリゴ糖−9糖1)α
−1→4結合のみで構成されるガラクトサミンの9糖
Ga1N、÷4GalN1→−p4GalN色と形状:
同上
味:同上
溶解性:同上
C: 44.17、 H: 6.88、 N : 8.
59、 O: 36.06予想される分子式:C,41
+□。1.037N96)分子量と構造式は下記の通り
。8. Name of substance: Galactosaminooligosaccharide-9 sugar 1) α
Galactosamine 9-saccharide Ga1N, ÷4GalN1→-p4GalN, composed of only -1→4 bonds Color and shape:
Taste: Same as above Solubility: Same as above C: 44.17, H: 6.88, N: 8.
59, O: 36.06 Expected molecular formula: C, 41
+□. 1.037N96) The molecular weight and structural formula are as follows.
分子量: 1467.9 融点:同上 第17図に紫外熱吸収スペクトルを示す。Molecular weight: 1467.9 Melting point: Same as above FIG. 17 shows the ultraviolet thermal absorption spectrum.
第18図に赤外部吸収スペクトルを示す。FIG. 18 shows an infrared absorption spectrum.
物質の名称:ガラクトサミンオリゴ−10糖α−1→4
結合のみで構成されるガラクトサミンの10糖
Ga1N、→4GaIN1→y*4GalN2)色と形
状二同上
3)味:同上
4)溶解性:同上
5)下記の元素分析値を示す。Name of substance: Galactosamine oligo-1decaccharide α-1→4
Galactosamine's 10-saccharide Ga1N, which is composed only of bonds, →4GaIN1→y*4GalN2) Color and shape 2) Same as above 3) Taste: Same as above 4) Solubility: Same as above 5) The following elemental analysis values are shown.
C: 44.23、H: 6.88、N : 8.60
、O: 40.23予想される分子式:CG、H工12
041N工。C: 44.23, H: 6.88, N: 8.60
, O: 40.23 Expected molecular formula: CG, H engineering 12
041N Eng.
6)分子量と構造式は下記の通り。6) The molecular weight and structural formula are as follows.
分子量: 1629.0 7)呈色反応:同上 8)旋光度 〔α〕ら’ : +201.2 7)呈色反応:同上 8)旋光度 〔α〕ら’ : +203.4 融点:同上 第19図に紫外部吸収スペクトルを示す。Molecular weight: 1629.0 7) Color reaction: same as above 8) Optical rotation [α] et al’: +201.2 7) Color reaction: same as above 8) Optical rotation [α] et’: +203.4 Melting point: Same as above FIG. 19 shows the ultraviolet absorption spectrum.
第20図に赤外部吸収スペクトルを示す。FIG. 20 shows the infrared absorption spectrum.
物質の名称:ガラクトサミンオリゴ−11糖α−1→4
結合のみで構成されるガラクトサミンの11M
Ga1N□+4GalN1−)7+4GalN色と形状
二同上
味:同上
溶解性:同上
下記の元素分析値を示す。Name of substance: Galactosamine oligo-11 sugar α-1→4
11M Ga1N□+4GalN1-)7+4GalN of galactosamine composed only of bonds Color and shape 2 Same as above Taste: Same as above Solubility: Same as above The following elemental analysis values are shown.
C: 44.27、H: 6.88、N : 8.61
. O: 40.25予想される分子式: CG1.H
izzO4sNx、6)分子量と構造式は下記の通り。C: 44.27, H: 6.88, N: 8.61
.. O: 40.25 Expected molecular formula: CG1. H
izzO4sNx, 6) The molecular weight and structural formula are as follows.
分子量: 1790.1 7)呈色反応二同上 8)旋光度 〔α〕も0: +205.2 融点:同上 第21図に紫外部吸収スペクトルを示す。Molecular weight: 1790.1 7) Color reaction 2 ditto 8) Optical rotation [α] is also 0: +205.2 Melting point: Same as above FIG. 21 shows the ultraviolet absorption spectrum.
第22図に赤外部吸収スペクトルを示す。FIG. 22 shows an infrared absorption spectrum.
物質の名称:ガラクトサミンオリゴ−12糖α−1→4
結合のみで構成されるガラクトサミンの12糖
Ga1N、−←4 G a l N □出フ4 G a
l N色と形状二同上
味:同上
溶解性二同上
5)下記の元素分析値を示す。Name of substance: Galactosamine oligo-12 sugar α-1→4
The 12-saccharide Ga1N of galactosamine, which is composed only of bonds, -←4 G a l N □ Output 4 Ga
l N Color and shape 2 Same as above Taste: Same as above Solubility 2 Same as above 5) The following elemental analysis values are shown.
C: 44.31、H: 6.87、N : 8.62
、O: 40.21予想される分子式: CtzHt3
404gNtz6)分子量と構造式は下記の通り。C: 44.31, H: 6.87, N: 8.62
, O: 40.21 Expected molecular formula: CtzHt3
404gNtz6) The molecular weight and structural formula are as follows.
分子量: 1951.2 7)呈色反応:同上 8)旋光度 (a )3’ : + 206.8 9)融点:同上 10)第23図に紫外部吸収スペクトルを示す。Molecular weight: 1951.2 7) Color reaction: same as above 8) Optical rotation (a) 3’: +206.8 9) Melting point: same as above 10) Figure 23 shows the ultraviolet absorption spectrum.
11)第24図に赤外部吸収スペクトルを示す。11) Figure 24 shows the infrared absorption spectrum.
(発明の効果)
本発明に係るガラクトサミノオリゴ糖は、いずれも文献
未載の新規化合物であって、医薬、農薬、食品添加物、
工業薬品及びそれらの中間体とじて有用な化合物である
。(Effects of the Invention) The galactosaminooligosaccharide according to the present invention is a new compound that has not yet been published in any literature, and can be used in medicines, agricultural chemicals, food additives,
It is a compound useful as industrial chemicals and their intermediates.
本発明に係る新規化合物の具体的用途としては、例えば
凝集剤、抗腫瘍剤等が大いに期待される。Specific applications of the novel compound according to the present invention include, for example, a flocculant, an antitumor agent, and the like.
第1図は、実施例1において分画されたガラクトサミノ
オリゴ糖のCトセファデックスC−25カラムクロマト
グラフイーのパターンを図示したものであり、第2図は
、ガラクトサミノオリゴ糖の分子旋光度と重合度との関
係を図示した図面である。
第3.5.7.9.11.13.15.17.19.2
1.23図は、ガラクトサミンオリゴ−2糖〜12糖の
紫外部吸収スペクトルをそれぞれ示した図面である。
第4.6.8,10.12.14.1G、■8.20.
22.24図は、ガラクトサミンオリゴ−2糖〜12糖
の赤外部吸収スペクトルをそれぞれ示した図面である。
代理人 弁理士 戸 1)親 男
0、D492
0−4〜間
tn O(JI OUI
NaCR(M)
(n−1)/n
手続補正書輸発)
昭和63年
8月15日
6、補正の対象 図 面
7、補正の内容
(1)第21図を別紙のとおり補正する。Figure 1 shows the C-tocephadex C-25 column chromatography pattern of the galactosaminooligosaccharide fractionated in Example 1, and Figure 2 shows the pattern of the galactosaminooligosaccharide fractionated on a C-tocephadex C-25 column. 1 is a diagram illustrating the relationship between molecular optical rotation and degree of polymerization. Section 3.5.7.9.11.13.15.17.19.2
Figure 1.23 is a diagram showing the ultraviolet absorption spectra of galactosamine oligo-disaccharides to dodecaccharides, respectively. 4.6.8, 10.12.14.1G, ■8.20.
Figures 22 and 24 are diagrams showing the infrared absorption spectra of galactosamine oligo-disaccharides to decasaccharides, respectively. Agent Patent Attorney Door 1) Parent Male 0, D492 0-4 ~ tn O (JI OUI NaCR (M) (n-1)/n Procedural Amendment Export) August 15, 1988 6, Amendment Target drawing 7, details of correction (1) Figure 21 will be corrected as shown in the attached sheet.
Claims (1)
式、化学式、表等があります▼ (但し、式中nは0〜10を表わす)。 2、α−1,4−ポリガラクトサミンを分解することを
特徴とする下記の式で示されるガラクトサミノオリゴ糖
の製造方法: ▲数式、化学式、表等があります▼ (但し、式中nは0〜10を表わす)。[Claims] 1. Galactosaminooligosaccharide represented by the following formula: ▲ Numerical formula, chemical formula, table, etc. ▼ (However, in the formula, n represents 0 to 10). 2. A method for producing galactosaminooligosaccharide represented by the formula below, which is characterized by decomposing α-1,4-polygalactosamine: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (However, in the formula, n is (represents 0 to 10).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16868188A JPH0219392A (en) | 1988-07-08 | 1988-07-08 | Galactosaminooligosaccahride and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16868188A JPH0219392A (en) | 1988-07-08 | 1988-07-08 | Galactosaminooligosaccahride and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0219392A true JPH0219392A (en) | 1990-01-23 |
JPH0576955B2 JPH0576955B2 (en) | 1993-10-25 |
Family
ID=15872503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP16868188A Granted JPH0219392A (en) | 1988-07-08 | 1988-07-08 | Galactosaminooligosaccahride and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0219392A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2014132468A1 (en) * | 2013-03-01 | 2017-02-02 | 国立研究開発法人理化学研究所 | Sugar chain compound and method for producing sugar chain compound |
-
1988
- 1988-07-08 JP JP16868188A patent/JPH0219392A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2014132468A1 (en) * | 2013-03-01 | 2017-02-02 | 国立研究開発法人理化学研究所 | Sugar chain compound and method for producing sugar chain compound |
Also Published As
Publication number | Publication date |
---|---|
JPH0576955B2 (en) | 1993-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001002597A1 (en) | Process for the preparation of the polysaccharides k4 and k5 from escherichia coli | |
CN113493776B (en) | Method for continuously preparing enzyme-digested ultralow-molecular-weight hyaluronic acid or salt thereof | |
JP3181337B2 (en) | Method for producing chitosan oligosaccharide mixture and method for producing chitin oligosaccharide mixture | |
JP3555957B2 (en) | Klebsiella pneumoniae, subsp. Novel strain of Pneumoniae and method for producing L-fucose-containing polysaccharide | |
JP3865801B2 (en) | Novel β-agarase, process for producing the same and use thereof | |
JP2763112B2 (en) | Water-soluble low molecular weight chitosan and method for producing the same | |
JP2894293B2 (en) | Galactanase S-39 and Bacillus sp. S-39 producing the same | |
JPH0219392A (en) | Galactosaminooligosaccahride and production thereof | |
JPH0219393A (en) | N-acetylogalactosaminooligosaccahride and production thereof | |
US5580763A (en) | Method for fermentation production of xanthan gum | |
JPH05320204A (en) | Production of n-acetylchitooligosaccharide | |
JP2001069975A (en) | Chitosanase | |
JP3656762B2 (en) | Manufacturing method of laminari triose | |
JP2772815B2 (en) | Method for producing microbial cellulosic material | |
WO2024131919A1 (en) | Paenibacillus and application thereof in preparation of tremella fuciformis oligosaccharide | |
JP3521950B2 (en) | Novel red algal mucopolysaccharide degrading enzyme, method for producing the same, and novel microorganism therefor | |
JPH04108395A (en) | Production of galactosamino-oligosaccharide | |
JPH0265789A (en) | Production of agar oligosaccharide | |
JP2894292B2 (en) | Galactanase S-2 and Bacillus sp. S-2 producing the same | |
JPH0363203A (en) | Antifungal agent | |
JPH02240007A (en) | Antifungous agent | |
JPH0797987B2 (en) | Novel β-agarase and method for producing the same | |
JPH0838172A (en) | New beta-agarase and production thereof | |
JPH04237491A (en) | New chitinase and its production | |
JPS5912274B2 (en) | Method for producing an enzyme that decomposes α-1,3-glucoside bonds |